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ABSTRACT 
In this thesis, cellular dynamics in skin under various pathological conditions were characterized 
utilizing multimodal multiphoton and optical coherence microscopy (MPM OCM).  Through these 
studies, additional insights were gained regarding the complex relationships among different skin 
constituents, and how abnormal pathological states can easily disrupt the homeostasis in the skin 
microenvironment.  At the molecular level, the robustness and cellular resolution of multimodal 
MPM OCM enabled longitudinal tracking of the effect of recombinant interleukin on the chemical 
environment in wounded skin.  At the cellular level, the efficacy of stem cell treatment on 
accelerating wound closure on diabetic skin was characterized.  Most importantly, the 
effectiveness of nonlinear microscopy on visualizing relationship between administered cells and 
local host environment was clearly demonstrated.  In addition, the potential of multimodal MPM 
OCM as a screening tool for pharmaceutical treatment was demonstrated through analyzing the 
mechanisms of a novel topical ointment on stimulating angiogenesis in non-healing diabetic 
wounds.  Though nonlinear microscopy possesses great potentials as a clinical diagnostic imaging 
system, significant limitations were revealed in this thesis that the skin miroenvironment cannot 
be further understood without technology capable of characterizing cellular dynamics in ways 
similar to the native environment.  To address this challenge, a video-rate multimodal microscopy 
system was developed, together with a multimodal 3D image analysis platform.  A pilot study was 
performed to demonstrate the combination of high-speed imaging and 3D analysis tool can 
potentially reinvent the way pathological environment of diseases were characterized.  By 
improving current imaging and analytical techniques for studying diseases in their natural states, 
optical imaging technology may have broader impact on biomedical research and natural sciences. 
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CHAPTER 1: INTRODUCTION 
1.1 Skin anatomy and cellular components 
Skin is the largest organ in human body, and the barrier that protects us from invasion of pathogens 
and loss of water.  It is composed of three main layers, including epidermis, dermis, and 
subcutaneous tissue as shown in Figure 1.1. 
 
Figure 1.1.  Architecture of skin and selected key components.  Reproduced with permission from [1]. 
 The epidermis is the outermost layer.  It is rich in cells and comprises the physical, biochemical, 
and the adaptive immunological barriers.  The main types of cells in this layer includes 
keratinocytes, melanocytes, and Langerhans cells, and the cell renewal process begins at the basal 
layer and moves in an upward direction toward the stratum corneum layer (Fig. 1.1).  Keratinocytes 
make about approximately 95% of the cell mass in the epidermis.  It is one of the early responders 
to external stimuli, such as radiation, and release important certain important pro-inflammatory 
cytokines to initiate inflammation [2].  In addition, keratinocyte migration and proliferation are 
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crucial processes that lead to wound closure.  Langerhans cells are a special type of dendritic cells, 
and the only type of dendritic cells resides in the epidermis.  Similar to keratinocytes, Langerhans 
cells also play prominent role in skin immunity.  As the only type of dendritic cells present in the 
epidermal layer, they are responsible for capturing and processing antigens present in the 
epidermis in order to activate proper immune response [3].  In addition, the epidermis does not 
contain blood vessels, and is nourished by diffusion from the dermis [4].  The dermis is the layer 
underneath the epidermis and is rich in collagen and various connective tissue for protecting the 
body from stress and strain.  It is composed of three major cell types, including fibroblasts, 
macrophages, and adipocytes, all of which play important roles in various biological functions and 
events.  In addition, the dermal layer contains blood vessels extended from the subcutaneous layer, 
which helps deliver the necessary oxygen and nutrients for cell metabolisms and survival.  The 
subcutaneous tissue, also called the hypodermis, is the lowermost layer of the skin, and it is rich 
in subcutaneous fat.  Subcutaneous fat is composed of adipocytes.  It functions as padding, energy 
reserve, and minor thermoregulation through insulation. 
1.2 Prevalence of diabetes and associated complications 
Diabetes is a metabolic disorder characterized by chronic hyperglycemia due to the lack of insulin 
production, or resistance to insulin action.  It has been found that approximately 9.4% of the 
American population is diagnosed with diabetes, and this metabolic disorder has remained the 7th 
leading cause of death in the United States [5].  In addition, due to the rise of obesity, the diabetes 
population is expected to double or triple by 2050 [6-8]. 
 Among the diabetes population, Type 2 diabetes accounts for 90% to 95% of all cases [5].  
Insulin resistance and subsequent elevation of blood glucose can result in generation of reactive 
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oxygen species (ROS) and advanced glycation end products that destroy proteins necessary for 
vessel and nerve structure and function [8].  Microvessel and nerve damage provide the basis for 
the majority of chronic diseases and conditions associated with diabetes, including cardiovascular 
and kidney diseases, retinopathy, glaucoma, peripheral neuropathy, and impaired skin wound 
healing [6, 9, 10].  Figure 1.2 below shows the prevalence of most common diabetes-associated 
complications. 
 
Figure 1.2.  Prevalence of most common diabetes-associated complications.  Adapted from [6] by permission from 
Oxford University Press. 
Diabetic patients are three to four times more likely to develop cardiovascular diseases 
compared to non-diabetic patients, and cardiovascular diseases cause up to 65% of all deaths in 
people with diabetes [10, 11].  In addition, studies have found that oxidative stress plays a crucial 
role in atherosclerosis, which accounts for the significant proportion of morbidity attribute to 
ischemic heart disease and stroke [10].  Another common complication is diabetic nephropathy, 
which is the chronic loss of kidney functions due to the loss of proteins in urine.  Studies suggest 
that the generations of ROS plays a key intermediate role in the development of diabetic 
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nephropathy, and this complication is also the single largest cause of end-stage renal disease [6, 
12].  In addition, impaired skin wound healing is another significant comorbid condition of 
diabetes.  Diabetes-induced peripheral neuropathy results in an increased number of skin lesions 
that can progress to non-healing ulcers, mainly because of poor peripheral microcirculation, often 
leading to non-traumatic lower-limb amputations [13].  In fact, diabetic foot ulcers contribute to 
approximately 60% of non-traumatic lower limb amputations among people age 20 years or older 
[5, 7, 14].  Such impaired wound healing in diabetic patients is caused by a variety of physiological 
abnormalities, including poor microcirculation, impaired growth factor production and 
macrophage function, and increased oxidative stress [6, 10, 15]. 
There are various types of treatment utilized in clinics and under development.  They can be 
roughly categorized into physical treatments and molecular/pharmacological treatments.  Physical 
treatments include applications of wound dressings directly onto the non-healed wounds for the 
purpose of creating a suitable environment that can promote proper healing.  Such environments 
should provide adequate moisture level and enhance circulation while promoting the formulation 
of granulated tissue, which is crucial during wound healing, as discussed previously [16].  
Treatments that fall under this category include different types of wound dressings, hyperbaric 
oxygen therapy, negative pressure wound therapy, and moist wound therapy [16-19].  
Pharmacological treatments involve ones that target non-healing wounds on the molecular level, 
such as angiogenesis-promoting treatments and various cell therapies [20].  Currently, there are 
more physical treatments approved for clinical use than molecular treatments, likely because more 
physical treatments have shown visible improvements for the general population of chronic wound 
patients.  In contrast, many novel molecular therapies have demonstrated promising results during 
preclinical studies, but have unfortunately failed during clinical trials.  While one cause could be 
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the wide range of patient response, as molecular treatments can be very sensitive to the cellular 
environment, another reason could be the incomplete understanding of the pharmacological 
mechanisms of the therapy during development.  For the above reason, advanced imaging 
technology such as the one that will be discussed in this thesis can be a reliable screening tool 
during drug production because it can provide researchers a method to directly observe cellular 
responses to the treatments in the native biological environment.  The information acquired by 
advanced imaging tools may therefore help researchers design molecular treatments that are more 
effective for the general population. 
1.3 Cellular dynamics in living tissue 
Cellular dynamics plays a crucial part of all diseases, as the cells are the first responders to any 
types of changes in the body and are responsible for sending necessary chemical signals to the rest 
of cellular microenvironment in response to the environmental cues [21].  Therefore, it is important 
to understand the cellular dynamics in the disease environment to understand the cause of certain 
diseases.   
One of the most studied group of cells is the inflammatory cells, as they are critical effectors 
and regulators of inflammation and the innate immune response [22, 23], and they are involved in 
almost all types of diseases.  One such example is the wound healing process, during which cells 
migrate collectively driven by active internal forces and invade the available space.  After 
wounding occurs, inflammatory cells such as neutrophils and macrophages soon flush into the 
wounded area to initiate an inflammatory reaction [23, 24], which subsequently triggers series of 
activities in the wound microenvironment that eventually lead to healing.  In the scenario of wound 
healing, immune cell dynamics is uniquely sensitive to invasion by infectious microorganisms and 
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tissue injury, and any abnormal alteration to the cellular functions and related chemical signaling 
can have detrimental effects on the wound healing ability. 
Besides wounding healing, cancerous tumor growth is also closely related to the cellular 
dynamics in the surrounding environment.  The environment of tumor microenvironment is akin 
to the inflammatory response in a healing wound, which involves collagen turnover, cell migration, 
and angiogenesis, which are all connected to cellular activities [25-27].  In fact, tumor 
microenvironment has been associated with chronic inflammation in the neoplastic tissue, and the 
disease outcome is highly correlated with the balance of immune system.  Clinical observations 
indicate that the immune system plays a dual role in tumor progression: while a balance favoring 
anti-tumor T lymphocyte responses often lead to improved clinical outcome, an immune balance 
favoring pro-tumor chronic innate immune cell activation often correlates with poor clinical 
outcome [28, 29]. 
 While wound healing and tumor microenvironment are just few of the examples, they 
illustrate the complex cellular system present in biological conditions.  Most importantly, they 
show the importance of understanding the cellular dynamics in a multimodal setting to fully 
comprehend how cells interact with their surrounding environment, and ways their activities affect 
disease outcome. 
1.4 Multimodal imaging for characterizing pathological conditions 
Recent development in multimodal imaging has brought new perspectives into clinical and pre-
clinical imaging.  To properly diagnose diseases and understand the underlying problems, it is 
necessary to achieve early diagnosis at the vascular and molecular level noninvasively, instead of 
purely based on symptoms.  To accomplish this goal, technological development in recent years 
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has place a strong emphasis on combining different imaging modalities to provide complementary 
information about morphology and different functional processes in vivo. 
 One of the best examples demonstrating the power of multimodal imaging is the development 
of position emission tomography (PET)-computed tomography (CT) imaging system.  Since its 
installation, PET-CT scanner has revolutionized medical diagnosis in many fields by providing 
precision of anatomical localization to functional imaging, which is lacking from pure PET 
imaging.  The benefits of the dual system have effectively changed the procedures of many 
radiation therapy, surgical planning, and cancer staging [30].  In addition, it has also allowed 
physicians to better understand the pathological conditions of the disease to make better diagnosis 
and avoid unnecessary radiation treatments [30, 31]. 
 Besides nuclear imaging, the concept of multimodal imaging has also been implemented in 
optical imaging of tissues and cells, especially in the field of microscopy.  Compared to nuclear 
imaging, optical imaging has the advantages of achieving cellular-level/sub-cellular resolution at 
the cost of imaging depth-of-field.  Therefore, optical imaging techniques are uniquely suited for 
characterizing the microenvironment and cellular dynamics in the diseased tissues.  Various 
research has successfully demonstrated the use of multimodal multiphoton microscopy for various 
diseases, including a combination of two-photon fluorescence (TPF), second harmonic generation 
(SHG), and coherent anti-Stokes Raman scattering (CARS) to visualize atherosclerotic lesions at 
microscopic resolution, allowing early diagnosis and proper treatment [32].  Nonlinear optical 
imaging techniques have been widely utilized in multimodal imaging due to their ability to achieve 
label-free imaging.  This advantage has allowed researchers to probe the microenvironment of a 
variety of diseases without artificially alter the chemical environment, such as fluorescent labeling.  
In recent years, multimodal nonlinear optical imaging has been widely utilized to study the tumor 
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microenvironment in different cancers [33, 34].  In addition to multimodal multiphoton 
microscopy, the nonlinear optical imaging techniques mentioned above can also be combined with 
optical coherence tomography (OCT) to provide additional information of the tissue anatomy at 
different scales and vasculature information.  This type of multimodal microscopy platform has 
been used to track the regeneration of various skin components and cell dynamics during wound 
healing [35], as shown by Figure 1.3. 
 
Figure 1.3.  Multimodal imaging of a skin wound.  (Top-left) standard photograph.  (Top-right) OCT.  (Bottom-left) 
OCT vasculature imaging.  (Bottom-right) fluorescence lifetime imaging microscopy [36]. 
 Since the concept of multimodal imaging has been utilized in biomedical imaging, numerous 
technological advances and biological discoveries have neem realized.  In addition, many medical 
treatments and diagnostic methods have been re-engineered.  However, significant improvements 
in technology and image processing techniques, such as imaging speed, real-time processing and 
better multimodal computational analysis tool are still needed to help biomedical imaging, 
especially optical imaging to become a part of the standard-of-care in disease diagnosis. 
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1.5 In vivo imaging of skin for clinical and research applications 
Imaging technologies, especially optical imaging provide measurements of the skin components 
at high resolution, which can be analyzed to assess the pathological conditions of a variety of skin-
related diseases, such as cancer, psoriasis and chronic wounds in a rapid, noninvasive, and 
objective manner.  The various optical imaging modalities can measure the scattering and 
absorption of light in different skin components, providing both qualitative and quantitative 
measurements of important biological markers, including vasculature structure, collagen 
orientation, cell dynamics, and metabolic states.  Due to its sensitivity to the above components in 
skin, optical imaging techniques are uniquely suited for imaging of skin for both clinical and pre-
clinical research applications. 
 Several optical imaging techniques have been proven beneficial in skin diseases diagnosis in 
both clinical and pre-clinical settings, including spectroscopy, fluorescence imaging, 
thermography, and perfusion imaging [37-41].  For example, near-infrared (NIR) spectroscopy has 
been shown to provide quantitative information of both the structural and chemical components of 
cutaneous tissue, specifically oxygen saturation, hemoglobin content, and water content [41].  
Burn wounds assessment is often based on visual observation by specialists to determine the burn 
depth, which can be highly subjective.  It has been demonstrated that NIR spectroscopy can 
distinguish superficial and full-thickness burn wounds based on oxygen saturation in a clinical 
setting, which provides more quantitative parameters for wound diagnosis [42].  In addition, OCT 
has been introduced into the dermatology discipline in 1997 as an emerging non-invasive imaging 
method based on interferometric technique [43].  In the past decade, numerous research has been 
conducted and published on OCT for skin, and the OCT technology has been proven reliable in 
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characterizing normal and pathologic skin morphology in a clinical setting [40, 44].  In wound 
healing, characteristically architectural changes that correlate with histological phases of 
cutaneous wound healing could be identified utilizing OCT [45].  In addition, OCT has shown 
success in differentiating different types of nonmelanoma skin cancer (NMSC), which comprises 
of basal cell carcinoma, squamous cell carcinoma, actinic keratosis.  Investigation of NMSC is a 
crucial part of daily dermatological practice, and the high-resolution OCT images of the different 
skin layers have assisted researchers and clinicians identifying the different subtypes of NMSC 
[46, 47]. 
 In recent years, multiphoton microscopy has also become an emerging imaging technology in 
characterizing different skin conditions.  Due to its capability of label-free imaging of different 
skin constituents at cellular-level resolution, it has received attentions from researchers and 
clinicians as a type of non-invasive tool to categorize skin cancers, assess wound healing 
microenvironment, and evaluate novel pharmaceutical agents [39, 44]. To achieve early detection 
of melanoma, clinical multiphoton microscope such as the one developed by Jenlab can perform 
in vivo non-invasive imaging of skin cancer, and provide the key characteristics for researchers to 
differentiate different disease stages [39, 48].  Multiphoton imaging, such as TPF has also been 
utilized to visualize the epithelial tissue to characterize the structural and metabolic heterogeneity 
in diabetic wounds [49].  When combining TPF with other multiphoton modalities, including SHG 
and fluorescence lifetime imaging (FLIM), multiphoton microscopy has the power to provide us 
information of different constituents of skin, and allow us to better understand the skin 
microenvironment under different disease conditions. 
 While optical imaging has proven its great potential for clinical applications, numerous crucial 
challenges remained to be solved for this technology to be practical in clinical setting.  For 
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example, the imaging system needs to be portable and user-friendly in order to be suitable for the 
highly dynamic environment in the hospitals.  This challenge has been addressed by several 
biotechnology companies, such as Jenlab, who developed portable multiphoton microscopy 
systems that have been widely utilized in human skin imaging [39, 48, 50, 51].  Utilizing this 
portable system, numerous studies have been conducted in which researchers discovered 
additional biomarkers and optical parameters to achieve better and earlier diagnosis of many skin 
diseases.  In addition to portability, an ideal clinical system should be capable of fast imaging with 
reliable accuracy.  While most of the current multiphoton imaging technology is not slow, it often 
takes several minutes to acquire an image with decent field of view.  Furthermore, due to the 
motion sensitive nature of microscopy, patient breathing can sometimes have an effect on image 
quality and therefore, require additional scanning time.  The long imaging duration can sometimes 
cause both physical and mental discomfort for the patients, and should definitely be addressed in 
future clinical system.  In recent years, multiple research groups have developed faster microscopy 
systems, which significantly reduced the scanning time without losing important information.  
These advancements in microscopy can potentially speed up its transitioning toward clinical 
settings, and allow these powerful imaging technologies to become a standard of practice in 
diagnosis of skin pathology. 
12 
 
1.6 Scope of the thesis 
 
Figure 1.4.  Organization of thesis. 
The goal of this thesis is to investigate the cellular dynamics and microenvironment of the skin 
in vivo, with emphasis on the process of wound healing.  In addition, to address technological 
challenges that need to be met to advance multimodal microscopy into clinical practices.  
Figure 1.4 above illustrates the components of the thesis.  This work focuses both on utilizing 
multimodal MPM and OCT/OCM to investigate various types of wound healing processes, and on 
developing the next-generation, video-rate multimodal imaging platform and analysis methods to 
better characterize cellular dynamics.  Starting with the introduction in this chapter, the second 
chapter gives a background on the biology of acute wound healing, the fundamental principles of 
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the imaging modalities in this thesis, and the first-generation multimodal MPM/OCT imaging 
system utilized in the studies presented in Chapters 3 through 5.  Chapter 3 presents the study on 
evaluating the effect of interleukin-12 on wound healing, and the related immune response during 
the process.  Chapters 4 and 5 discuss two studies focusing on characterizing some of the novel 
treatments for non-healing diabetic wounds, including stem cell treatment and topical ointment.  
These three chapters focus on utilizing multimodal microscopy to characterize cellular dynamics 
under various skin microenvironments, and on exploring the potentials of this imaging platform 
as a reliable screening tool for the evaluation of novel treatments.  Some of the challenges and 
drawbacks from the studies presented in the above three chapters then redirects the rest of the 
thesis to emphasize more on the engineering aspects of biomedical imaging, as presented in 
Chapters 6 and 7.  Chapter 6 will present the construction of a fast-scanning multimodal imaging 
platform, which can perform large field-of-view 3D in vivo imaging of cellular activities.  The 
imaging system presented here is capable of performing cross-modality co-registration in ways 
that would be challenging using other imaging techniques.  As a follow-up to Chapter 6, Chapter 7 
focuses on the development of a 3D multimodal image analysis platform for performing cross-
modality analysis of microscopy images.  This analysis will be one of the first of its kind to be 
capable of analyzing in vivo 3D microscopy datasets in a spatially and temporally co-registered 
manner, which can allow researchers to characterize the microenvironment of diseases in a way 
that is more biologically realistic.  As a proof of concept, the image analysis platform is tested to 
characterize the cellular environment in wounded skin.  Finally, Chapter 8 draws conclusions and 
presents proposed future work and possible directions in this field of research. 
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CHAPTER 2: BACKGROUND 
In this chapter, the biological background of acute wound healing is introduced.  In addition, the 
theory and operation principles for multiphoton microscopy and optical coherence 
tomography/microscopy are discussed.  Furthermore, the first-generation multimodal 
multiphoton/optical coherence microscopy is introduced, which is the imaging system utilized in 
the studies that will be presented in Chapters 3 through 5. 
2.1 Acute wound healing 
Wound healing is one of the most important biological phenomena in our body.  It is a dynamic, 
interactive process that typically consists of three phases overlapping in time: inflammation, 
proliferation, and tissue remodeling [13, 52].  Figure 1 outlines the normal wound healing 
progression and selected major events occurring at each stage. 
 
Figure 2.1.  Progression of normal wound healing.  Reprinted from [53] with permission from Elsevier. 
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2.1.1 Inflammation 
Inflammation phase is an essential phase of healing, during which cytokines, growth factors, and 
inflammatory cells including neutrophils and macrophages are recruited to the wound site to 
phagocytose the bacteria and dead cells in order to prepare the wound for healing [13, 54].  The 
inflammation phase of wound healing usually lasts between 24 and 48 hours, but may persist up 
to two weeks in some cases.  While this is an essential healing stage, prolong inflammation at the 
wound site can have detrimental effect to the healing progress such as non-healing diabetic 
wounds.  The conditions of non-healing wounds will be further discussed in Chapters 4 and 5.  
Figure 2.2 below illustrate the microenvironment of the wounded skin during inflammation phase. 
 
Figure 2.2.  Microenvironment of the wounded skin during inflammation stage.  Growth factors necessary for cell 
movement into the wound are shown.  Reproduced with permission from [13], Copyright Massachusetts Medical 
Society. 
 When the tissue is injured, the hemostasis of vasculature network is disrupted.  In response to 
the condition, platelets form blood clots at the wounded site to provide provisional extracellular 
matrix (ECM) for cell migration [13].  With this temporary matrix scaffold in place, the healing 
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cascade is initiated via the release of chemoattractants and growth factors.  This process 
subsequently attracts leukocytes, including neutrophils and macrophages infiltrate the wounded 
area and assist in phagocytosis. 
2.1.2 Proliferation 
Fibroblast migration and proliferation predominates the second phase, which also includes 
synthesis of collagen necessary for tissue repair, re-epithelialization of the epidermis, 
angiogenesis, and myofibroblast-mediated wound contraction and closure [53, 54].  Figure 2.3 
shows the cellular activities in wounded skin during proliferation phase. 
 
Figure 2.3.  Cellular activities in wound during proliferation phase.  Reproduced with permission from [13], Copyright 
Massachusetts Medical Society. 
Re-epithelialization begins with keratinocytes migration in respond to the wound edge, after 
which the keratinocytes will begin to proliferate at the wounded region to ensure an adequate 
supply of cells to migrate and cover the wound [53].  Another important event during proliferation 
phase is the reconstitution of the dermis, which is characterized by the formation of the granulation 
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tissue.  Upon formation, cells including macrophages, fibroblasts, and blood vessels can then move 
into the wound at the same time to provide the necessary nutrients for healing.  During the 
formation of granulation tissue, angiogenesis also takes place at the wound site, which is initiated 
by the presence of injured vasculatures and the hypoxic environment of the wound [13, 55].  It is 
a complex process which relies on ECM in the wound bed as well as the cellular activities in the 
skin microenvironment, and it is also an essential process to ensure successful collagen remodeling 
and tissue repair.  Once the wound is filled with granulation tissue, angiogenesis ceases and many 
of the new blood vessels will disintegrate as a result of apoptosis [56], as the additional supply of 
oxygen and nutrients is no longer required.  Furthermore, skin contraction is another important 
process during the proliferation phase to reach proper wound closure.  During healing, fibroblasts 
assume a myofiobroblast phenotype to initialize connective tissue compaction and the contraction 
of the wound. 
2.1.3 Tissue remodeling 
During the tissue remodeling phase, the deposition of ECM takes place with appropriate collagen 
abundance and alignment [13, 53].  This phase takes the most amount of time, sometimes years, 
and it is worth noting that wounds never attain the same breaking strength as uninjured skin.  At 
maximal strength, a previous injured skin is only about 70% as strong as normal skin [57].  One 
of the characteristics of the remodeling phase is the change of ECM composition.  Normally, type I 
collagen account for approximately 80% of collagens, and type III collagen constitutes 
approximately 10% of collagen in the dermis [53].  However, during the early stages of healing, 
the wound is filled mostly by granulation tissue, which is rich in type III collagen.  During the 
remodeling phase, the dermis of skin will gradually return to the stable preinjury phenotype as 
type III collagen degrades and is replaced by type I collagen. 
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2.2 Multiphoton microscopy  
Multiphoton microscopy (MPM) has been utilized in biomedical research since the early 1990s 
[58-61].  Multiphoton microscopy techniques are based on nonlinear optical processes.  Compared 
to conventional fluorescence imaging, MPM has the advantages of exciting numerous 
fluorophores and intrinsic molecular contrast from different physical mechanisms, deeper imaging 
penetration depth, and reduced photodamage due to the use of near infrared (NIR) excitation 
sources, which makes it ideal for in vivo imaging [62-64].  In this section, some of the most 
important and commonly used imaging modalities adopted in this thesis are introduced, including 
TPF, SHG, and FLIM.  Their physical mechanisms and sources of contrast are discussed in order 
to provide context for the imaging results described later in this thesis. 
2.2.1 Two-photon fluorescence (TPF) 
Two-photon fluorescence (TPF) microscopy is one of the most widely used imaging techniques in 
nonlinear optical microscopy.  The nonlinear contrast is based on third-order nonlinear interaction 
of the light and the imaging target at the focus of the microscopy objective [64].  Unlike 
conventional one-photon fluorescence, TPF relies on the simultaneous absorption of two higher-
wavelength photons whose combined energy is sufficient to generate a molecular transition to an 
excited state, as shown in Figure 2.4.   
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Figure 2.4. (Left) Energy level diagram of TPF.  a, b: frequencies of the incident photon pair; f frequency of the 
emitted fluorescence photon.  (Right) in vivo TPF of bone marrow-derived immune cells from GFP-engrafted mouse 
skin.  Scale bar: 50 m 
In addition, since the two-photon absorption process is proportional to the square of the 
excitation intensity, out-of-focus excitation is avoided, resulting in reduced overall photobleaching 
and enhanced lateral resolution [61, 65].  The collected TPF fluorescence intensity is given by 
Equations 2.1 and 2.2 [65]: 
                                 (2.1) 
where the excitation intensity I(t) in photon cm2 s-1 is: 
,                                           (2.2) 
 is the molecular cross section,  is the quantum yield, exc is the excitation wavelength, P(t) is 
the instantaneous power on the illuminated area , NA is the numerical aperture of the microscope 
objective, and h and c are Planck’s constant and the speed of light in vacuum, respectively.   is a 
factor that takes into account the collection efficiency of the microscope. 
Due to this nonlinear process, a NIR laser source can be utilized, instead of ultraviolet 
(UV)-visible light source, to excite extrinsic or intrinsic fluorescent biomolecules in the biological 
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tissue.  In addition, the use of this longer-wavelength light source allows deeper imaging 
penetration depth, which is highly beneficial for in vivo imaging.  The widespread use of TPF for 
imaging in biological samples is also due to the fact that commonly used fluorescent molecules 
and a variety of in vivo biomolecules can be efficiently excited with two-photon excitation (TPE) 
[66].  The probability of a nonlinear interaction between excitation light beam and a fluorescent 
molecule depends on its two- or multiphoton cross-section.  Table 2.1 below illustrates the TPE 
cross-section and excitation wavelengths of a variety of fluorescent molecules, including those 
that are important in this thesis [65].  The fluorescent molecules that are heavily involved in this 
studies presented in this thesis includes EGFP, NADH, and collagen. 
Table 2-1 TPE excitation wavelength and cross section data of selected fluorescent molecules.  Adapted from [65], 
reproduced with permission. 
 
2.2.2 Second harmonic generation (SHG) 
Second harmonic generation (SHG) is a second-order nonlinear interaction between the excitation 
light source and a material with noncentrosymmetric molecular organization [67, 68].  SHG signals 
21 
 
emerge from the material at precisely half the wavelength (twice the frequency) of the light 
entering the material, as shown by the energy diagram in Figure 2.5, along with a SHG image of 
the collagen from mouse skin. 
 
Figure 2.5. (Left) energy diagram of SHG. i: frequency of the incident photon.  (Right) SHG image of the collagen 
from mouse skin.  Scale bar: 200 m. 
 This second-order nonlinear process can be understood by first looking at the nonlinear 
polarization for a material as defined by Equation 2.3 [67, 69]: 
(1) (2) (3) ...P E EE EEE                                         (2.3) 
where P represents the induced polarization vector, (i)is the ith-order nonlinear susceptibility 
tensor, and E represents the vector electric field.  Since SHG is a second-order nonlinear process, 
this process can be described as: 
,                    (2.4) 
given 
                                        (2.5) 
Where A is the field amplitude,  is the angular frequency of the wave and c.c. represents the 
complex conjugate of the previous term.  Equation 2.4 shows that the SHG process results in a 
frequency-doubled photon conversion (2), as shown by the Jablonski diagram in Figure 2.2.  The 
P = c (2)E2 = c (2)(A2 exp[- j2wt]+ AA*)+ c.c.
E(t) = Aexp[- jwt]+ c.c.
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most important biological molecules and structures that can be visualized by SHG include 
collagen, myosin, and tubulin [62, 67].  In skin imaging, SHG is primarily utilized to visualize 
collagen structure, which includes many different subtypes.  Among all, Type 1 collagen 
contributes to the majority of SHG signal [67, 70].  
2.2.3 Fluorescence lifetime imaging microscopy (FLIM) 
Compared to fluorescence imaging, the contrast in fluorescence lifetime imaging microscopy 
(FLIM) comes from the excited state lifetime, rather than the intensity, of a fluorophore [59].  In 
biomedical imaging, FLIM has been widely used to probe the metabolic activity in biological 
tissues.  Specifically, studies have shown FLIM to be a reliable tool to measure the intrinsic 
fluorescence lifetime of intracellular reduced nicotinamide adenine dinucleotide (NADH) in the 
cytoplasm of cells, which is an important coenzyme involved in the reduction-oxidation (redox) 
reaction in cells [59, 71-73].  One of the most important functions of redox reaction is the 
production of adenosine triphosphate (ATP) molecules.  ATP is the main currency of cellular 
energy, and the production pathway of ATP is highly sensitive to the homeostasis of cellular 
environment.  Hydrolysis of ATP molecule releases energy, and it is important to all cellular 
functions. 
 NADH can exist in two different states: free in the cytoplasm or bound to certain enzymes.  By 
tracking the relative contributions of NADH at these two different states through lifetime imaging, 
the metabolic activity in the cells can be sensitively probed.  The metabolic activity in cells is 
closely related to the energy production process in cells, and the two processes that will be focused 
on in the thesis include glycolysis and oxidative phosphorylation [72].  Glycolysis is the anaerobic 
metabolic pathway that occurs in the cytoplasm of cells, converting glucose into pyruvate.  During 
this process, only two NADH and two ATP molecules are produced, leading to glycolysis being 
23 
 
considered as the less efficient ATP production pathway.  The metabolic pathway of glycolysis 
can be summarized by the diagram in Figure 2.6. 
 
Figure 2.6. Glycolysis process in the cytoplasm; GADP = glyceraldehyde 3-phosphate; DHAP = dihydroxyacetone 
phosphate. 
 In contrast to glycolysis, oxidative phosphorylation is the aerobic metabolic pathway that 
involves the use of oxygen.  It is the more efficient ATP production pathway that takes place inside 
the mitochondria, and can yield between 30 to 36 ATP molecules.  Figure 2.7 below illustrates this 
metabolic process. 
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Figure 2.7.  Oxidative phosphorylation process inside the mitochondria.  Adapted from [74]. 
 Oxidative phosphorylation involves two processes: the citric acid cycle (TCA) and the electron 
transport chain.  Under aerobic condition, pyruvate generated from glycolysis process is converted 
to acetyl Coenzyme A (acetyl CoA), and enters the TCA cycle in the matrix of the mitochondria, 
as shown in Figure 2.7.  During this process, 3 NADH and one FADH2 molecules are produced, 
which then enter the electron transport chain at the mitochondrial inner membrane.  The electron 
transport chain comprises an enzymatic series of electron donors and acceptors.  Electron donors, 
such as NADH and FADH2 bind to electron acceptors Complex I and Complex II, respectively, 
and electrons are released through reduction reactions.  The electrons generated by Complex I and 
II are then passed to the more electronegative acceptors in the order of coenzyme Q, Complex III, 
cytochrome c, and finally to Complex IV.  Complex IV then uses the electron and hydrogen ions 
created during this process to reduce oxygen to water.  Molecular oxygen is the terminal electron 
acceptor in the electron transport chain, as it is the most electronegative acceptor.  During this 
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electron transportation process, a proton gradient across the mitochondrial inner membrane is 
created, as shown in Figure 2.7, and the resulting transmembrane proton gradient is utilized by 
ATP synthase to produce ATP.  Each reduction reaction of NADH can create a proton gradient 
that can be used to produce about 2.5 ATP molecules, and each proton gradient created by the 
reduction of FADH2 can be utilized to produce about 1.5 ATP molecules. 
 From the processes described above, it can be seen that NADH free in the cytoplasm is more 
closely associated with glycolysis process, while the NADH bound to proteins in the mitochondria 
is associated with oxidative phosphorylation.  Therefore, by examining the change in NADH 
lifetime, the state of the metabolic activity can be assessed.  In general, the mean NADH 
fluorescence lifetime can be calculated from the corresponding fit parameters in Equation 2.6. 
                                                  (2.6) 
where m is the mean NADH lifetime, a1 and a2 are the relative concentrations of free NADH and 
protein-bound NADH, respectively, and 1 and 2 are the excited state lifetimes of free NADH and 
protein-bound NADH, respectively [75-77].  Between the two states of NADH, the bound NADH 
has a longer lifetime than the free NADH. 
2.3 Optical coherence tomography and microscopy (OCT/OCM) 
Optical coherence tomography has been widely utilized both in biomedical research and clinical 
applications [78-80], and the benefits of performing noninvasive cross-sectional imaging of 
internal structures in biological tissues by measuring their optical reflections [81].  In this section, 
the working principles of OCT and OCM are presented, and the distinctions between OCT and 
OCM are discussed. 
tm = a1t1 + a2t 2
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2.3.1 Principles of OCT operation 
The operating principles of OCT are analogous to ultrasound imaging, in which the depth-
dependent optical scattering information can be determined by focusing a laser beam into a sample 
and measuring the magnitude and time delay of backscattered light.  OCT is based on an optical 
measurement technique known as low coherence interferometry, which performs correlation 
measurements by interfering backscattered light from the sample with light that has traveled 
through a reference path with a known time delay [82].  Figure 2.8 below illustrates a diagram of 
Michelson interferometer, which is a common configuration for optical interferometry. 
 
Figure 2.8.  Schematic diagram of a Michelson interferometer. 
 The incident light is divided into a sample beam (Es) and a reference beam (Er), and the detector 
measures the output intensity, which can be described by Equation 2.7. 
2 2( , ) 2 ( ) cos(2 ( ))r s s r r sI t E E G E E k z z                                       (2.7) 
where G() is the autocorrelation function of the laser source, k is the wave number 2π/λ, and 
(zr - zs) is the path length difference between reference and sample beams.  The last term in the 
equation is the interference term, which is proportional to the reflection in the sample.  The 
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modulation caused by a phase shift in the reference arm is used to distinguish the interference term 
from the DC values.  By scanning a focused beam transversely across the sample and combing the 
backscattered light with the reference beam, the three-dimensional structure of a sample with 
micron-scale resolution can be reconstructed. 
 OCT can be performed in both time domain and spectral domain.  In time domain OCT, the 
length of the reference arm in an interferometer is rapidly scanned over a distance that corresponds 
to the imaging-depth range [83].  Alternatively, mechanical scanning of the reference arm is not 
required in spectral domain OCT, and a spectrometer is utilized to measure the spectral 
interference pattern [83, 84].  Figure 2.9 below demonstrates the differences in instrumentation 
setup between time domain and spectral domain OCT. 
 
Figure 2.9.  (Left) time domain OCT setup.  (Right) spectral domain OCT setup. 
2.3.2 Distinctions between OCT and OCM 
OCM operates under the same principles as OCT, but instead utilizes objectives with higher 
numerical aperture (NA) to achieve higher transverse resolution.  This improvement in resolution 
comes at the cost of imaging depth-of-field.  Because of this limited depth of field, it is more 
efficient to perform en face imaging, rather than cross-sectional imaging.  OCT utilizes a relatively 
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low NA objective which provides a resolution between 10 and 30 m over a depth ranges from 
millimeters to centimeters.  In contrast, the use to high NA objectives in OCM allows a very tight 
focus on the sample, which gives sub-cellular resolution over a narrow depth range.  This tradeoff 
between transverse resolution and depth-of-field is demonstrated in Figure 2.10. 
 
Figure 2.10.  Comparison of the focusing scheme; d = depth of field. 
2.3.3 Vasculature imaging 
Besides being able to visualize tissue structure based on optical scattering properties, OCT/OCM 
can also be utilized to visualize and quantify blood flow in living tissue.  Figure 2.11 below 
provides an example of vasculature imaging in living skin.  The source of contrast is based on 
detecting the dynamic changes in the optical scattering due to the blood flow, and therefore OCT 
vasculature imaging can be performed in a label-free manner.  The first method used to detect 
frequency shift due to the Doppler effect was Doppler OCT, which provides information of blood 
flow by measuring the Doppler shift induced by the moving scatterers in the blood [85].  In 
addition, other methods have been developed to perform vasculature imaging, including phase-
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variance OCT (PV-OCT), speckle-variance OCT (SV-OCT), and optical microangiography 
(OMAG)[35, 80, 86-88]. 
 
Figure 2.11.  OCT structural and vasculature imaging of a wound on mouse ear.  The images are generated through 
maximum intensity projection of the OCT volumetric data.  Scale bar: 500 mm applies to all. 
 Phase-sensitive methods are established by analyzing the dynamic changes in the phase term 
of the OCT signal.  During blood flow, the axial displacement of the scatters in blood, such as red 
blood cells, adds a Doppler shift to the carrier frequency, which then changes the phase of the OCT 
signal which can be sensitively measured.  SV-OCT is similar to PV-OCT, which is also based on 
measuring the change in the scattering signal at a given location overtime.  It visualizes 
microvasculature by calculating the interline or interframe speckle variance of the intensity-based 
structural OCT images [89].  OMAG is capable to producing 3D images of dynamic blood 
perfusion with microcirculatory tissue bed.  It utilizes phase modulation of the reference light and 
a Hilbert transform to separate signal that is backscattered by static particles from moving particles 
[82].  All methods mentioned above have been shown to provide strong contrast from vasculature 
in a variety of settings. 
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2.4 First-generation multimodal multiphoton/optical coherence microscopy 
system 
The studies presented in Chapters 3 through 5 were performed utilizing the first-generation 
multimodal microscope, which includes TPF, SHG, FLIM, and PV-OCT modalities [35, 75, 90].  
The capability to perform both MPM and OCT imaging in one system without the need to move 
the samples provides both the structural and the functional information of the samples.  The system 
utilizes a tunable titanium:sapphire laser (Mai Tai HP, Spectra Physics) as the excitation source.  
TPF and SHG imaging are usually used for visualizing GFP-engrafted/fluorescently-labeled cells 
and collagen structure, respectively, and the center wavelength of excitation is at 920 nm to achieve 
optical excitation.  The laser is directed through two scanning mirrors and the sample arm, and is 
focused onto the skin sing a 0.95-NA objective lens (XLUMP20X, Olympus).  TPF and SHG 
signals can be acquired simultaneously utilizing two photomultiplier tubes (PMT) and proper 
dichroic mirrors, as shown in Figure 2.12.  With this setup, spatial co-registration of TPF and SHG 
is easily achieved. 
 In addition, the PMTs for TPF and SHG detection can be replaced with the 16-channel PMTs 
shown in Figure 2.12 for FLIM imaging, which is performed at 730 nm wavelength for NADH 
excitation.  The FLIM signals are detected by a 16-channel PMT (PML-16-C; Becker-Hickl) and 
captured with a time-correlated single photon counting data acquisition board (SPC-150; Becker-
Hickl).  As shown in Figure 2.12, a portion of the laser source is directed through PCF for spectral 
broadening to perform OCT imaging, which is done with a center wavelength of excitation at 
800 nm.  The spectral-domain OCT system was based on a free-space Michelson interferometer 
with a spectrometer in the detection arm.  The OCT axial and transverse resolutions are 5 and 
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25 m, respectively.  To switch from MPM to OCT imaging, a change of objective is needed, 
which can be done in than a minute without moving the sample. 
 
Figure 2.12.  Schematic of the first-generation multimodal microscope system.  PMTs 1 and 2 can be replaced with 
the 16-channel PMTs for FLIM imaging.  BS, beam splitter; HWP, half-wave plate; L, lens; PCF, photonic crystal 
fiber; PBS, polarized beam splitter; M, mirror; SM, scanning mirror; DM, dichroic mirror; FB, fiber bundle; 
DG, diffractive grating; LSC, line-scan camera. 
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CHAPTER 3: IMMUNE RESPONSE IN SKIN REGENERATION 
In this chapter, a study on examining the effect of interleukin-12 (IL-12) on skin regeneration 
in vivo during skin wound healing is presented.  A custom-built multimodal microscopy system 
equipped with SHG and FLIM was utilized to investigate the collagen structure and cellular 
metabolic activity, respectively.  These results can elucidate insights into the response mechanism 
of IL-12 and its effect on the dynamics of various cellular components during wound healing. 
3.1 Interleukin-12 and the regulation of immunity 
IL-12 is a pro-inflammatory cytokine primarily produced by monocytes, macrophages, and 
dendritic cells that is known to be involved in the development of cell-mediated immunity, and to 
form a link between innate resistance and adaptive immunity [91, 92].  Figure 3.1 illustrates the 
relationship between IL-12 and the rest of the immune cells. 
 
Figure 3.1.  Relationship between IL-12 and different immune cells, and how IL-12 regulates the Immune activity.  
Adapted from [91] with permission from Springer Nature. 
The content of this Chapter was based on reference [96]: Li J, et al, Biomed. Opt. Express (2015) with permission from 
Optical Society of America. 
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  IL-12 induces the production of interferon-gamma (IFN-), which is a cytokine with antiviral 
activity and has an essential role in resistance to many foreign pathogens [91].  Once released, 
IFN- can interact with nearby cells through paracrine signaling to ensure the continuous presence 
of essential cytokines and immune cells [52].  Recent studies have found that administration of 
IL-12 post-irradiation significantly reduces the size of burn wounds caused by radiation exposure, 
and can also increase the survival rate in lethally irradiated nonhuman primates [92, 93].  To better 
understand the functions of IL-12 in actively healing skin, a technology capable of noninvasive 
in vivo monitoring of the wounded skin and the cellular activity at single-cell resolution is 
imperative. 
 Injury triggers a complex and organized cascade of cellular and biochemical events that 
eventually lead to healed skin.  However, this healed skin is not as structurally and functional 
strong as non-wounded skin [94].  In general, there are three stages during the process of wound 
healing: inflammation, proliferation, and remodeling [13, 52, 94].  The inflammatory stage is an 
essential phase of healing, during which cytokines, growth factors, and immune cells including 
macrophage and dendritic cells are released and activated [52, 91].  During the proliferation stage, 
the main activities involve skin resurfacing where formation of epithelium occurs to cover the 
wound surface, and dermal restoration including angiogenesis to pervade the wound space [13, 
53].  Once the new tissue is formed, the remodeling phase begins to restore tissue integrity and 
functional competence [53].  While studies have discovered that IL-12 significantly reduces the 
severity of burn wounds and related acute radiation syndrome, the mode of action of this cytokine 
in minimizing radiation-induced cutaneous damage is still relatively unknown [92].  By 
investigating the change in the microenvironment of wounded skin after the administration of 
34 
 
IL-12, we may gain valuable insights into the underlying mechanisms of how IL-12 assists in the 
skin recovery after radiation damages. 
 To accomplish the above goals, multiphoton microscopy, including SHG microscopy and 
FLIM, is uniquely suited to study the skin microenvironment in vivo due to the high resolution and 
label-free imaging capabilities [35, 50, 72, 73].  In this study, structural and metabolic changes in 
the skin were tracked using SHG and FLIM, respectively, to evaluate the effect of recombinant 
murine IL-12 (rMuIL-12) on skin.  The acquired information has the potential to provide additional 
insights regarding the role of IL-12 in wounded skin. 
3.2 Effect of recombinant interleukin-12 on murine skin regeneration and cell 
dynamics 
3.2.1 Animal procedures and study design 
Female C57BL/6 wild-type mice were used in the study.  Prior to wounding under anesthesia (1% 
isofluorane gas mixed with 1.5% oxygen), the hair on the lower dorsal skin was first shaved with 
electric clippers.  For the region to be wounded and imaged, the remaining hair was further 
removed carefully using surgical forceps under a surgical microscope.  The shaved skin was then 
cleaned with 70% ethanol, and full thickness excisional wounds were made using a sterile 1 mm 
biopsy punch.  The wounds were left uncovered, and no analgesics or additional anti-inflammatory 
agents were administered to the mice during the course of the study. 
 Both the rMuIL-12 and placebo compounds were provided by Neumedicines, Inc.  Three 
experimental groups (n=5 per group) were investigated: non-wounded mice with rMuIL-12 
injection, wounded mice with placebo injection, and wounded mice with rMuIL-12 injection.  The 
non-wounded group was imaged using the multimodal microscope on days 0, 1 (pre-drug 
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injection), 2, 3, 7, and 14.  The two wounded groups were imaged on days 0 (pre-wounding), 1 
(pre-drug injection), 2, 3, 5, 7, 14, 21, and 28.  Approximately 8 hours after wounding and imaging 
on day 1, prepared rMuIL-12 (40 ng/mouse) or placebo were administered by a single 
subcutaneous injection on the nape of the neck using a syringe needle with a dose volume of 
100 L/mouse. 
3.2.2 Image acquisition and processing 
SHG imaging of the skin around the wound was acquired with dimensions of approximately 
2x2 mm2 using a motorized stage to scan in the lateral dimensions.  Images were acquired as 10 
by 10 frame mosaics that were stitched together in post-processing using Matlab and ImageJ.  In 
addition, volumetric SHG data with dimensions of 185x185 m2 across a depth of approximately 
80 m with 6-8 m incremental steps were also acquired from around the wound.  FLIM imaging 
was performed on four manually selected locations on the skin around the wound to sample the 
region.  Time-correlated single photon counting (TCSPC) was performed using a commercial 
TCSPC data acquisition board (SPC-150, Becker-Hickl) to capture the fluorescence decay curves.  
The images were processed with SPCimage software (Becker-Hickl), and the average fluorescence 
lifetime of the entire image was calculated.  The average and standard deviation of the fluorescence 
lifetimes were evaluated, and one-way ANOVA combined with Tukey honest significant 
difference (HSD) test was used to determine the significance level. 
3.2.3 Collagen alignment analysis 
Collagen alignment analysis was performed on the SHG images of all animals.  On each SHG 
image, five small areas with dimensions of approximately 150x150 pixels (108x108 m2) within 
500 m from the edge of the wounds were manually selected to avoid the dark signal-free regions 
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in the hair follicles and the wounds.  Also, these small image areas were manually selected because 
the change in collagen structure was more pronounced closer to the wound.  Two-dimensional 
spatial Fourier transforms (FT) were performed on these small image blocks, and the FT magnitude 
images were converted into binary images based on a specified threshold.  An ellipse-fit was then 
performed on these binary images utilizing the Matlab Image Processing Toolbox function and the 
parametric form of the ellipse equation [95].  To quantify the collagen structure around the wound 
bed, eccentricity of the ellipse was used, which was defined by Matlab as the ratio of the distance 
between the foci of the ellipse and its major axis length.  The value was between 0 and 1.  A value 
closer to 0 suggested that the collagen fibers in the selected regions were isotropically distributed, 
and a value closer to 1 suggested that the collagen fibers were more aligned in a particular 
direction.  The average and standard deviation of the eccentricity values were calculated, and one-
way ANOVA combined with Tukey HSD test was utilized to evaluate the significance level. 
3.2.4 SHG imaging of collagen structure and alignment during wound healing 
SHG was utilized to track the progress of wound healing and to evaluate the collagen structure 
around the wound bed within the first 100 m depth of the dermal skin layer.  Figure 3.2 below 
illustrates the progress of wound healing during the one-month period.  SHG imaging showed that 
there appeared to have an active collagen contraction between days 5 and 14 [96], which is a part 
of the remodeling stage of wound healing characterized by a more aligned collagen structure [53].  
By days 21 and 28, the collagen structure on top of the wounds appeared to be mostly restored, 
but with a lower collagen fiber density compared to the surrounding non-wounded areas.  The 
weaker SHG signals observed in the wound bed suggested that there was a lower type I collagen 
density since type I collagen gives stronger SHG signals [97].  It was also observed that the wounds 
did not close isotropically even though a circular wound was created.  Instead, the wound edge 
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contracted more in one direction than the other, as illustrated on day 14 in Figure 3.2.  This 
observation could be related to the Langer’s lines, which correspond to the natural orientation of 
the underlying collagen fibers.  Langer’s lines have an important relationship with wound healing 
because scarring is more apparent when the wound is against the orientation of Langer’s lines, and 
therefore Langer’s lines can affect the collagen tension around the wound edge during wound 
healing.  However, additional studies will be needed to confirm the above observations. 
 
Figure 3.2. Representative SHG images of the wounded skin from the wounded group with rMuIL-12 injection 
showing wound healing progression.  Scale bar: 200 m applies to all [96]. 
 To evaluate the change in collagen structure during the process of wound healing, five small 
areas around the wound bed on each SHG image of each animal were manually selected, and an 
ellipse-fit was performed on the magnitude of the 2D Fourier transform of each small image area 
as describe in Section 3.2.3 [98].  The eccentricity value of the ellipse was used to evaluate the 
preferred orientation of the collagen fibers immediately around the wound bed, which can be an 
implication of collagen contraction since the collagen fibers are stretched toward the center of the 
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wound during the contraction process to achieve wound closure [13, 53].  A value closer to 0 
suggested that the collagen fibers around the wound were isotropically distributed, and were more 
similar to the “basket-weave” structure of a non-wounded skin as shown in Figure 3.3 [52, 94, 99].  
A value closer to 1 suggested that the collagen fibers were oriented in a particular direction 
(Fig. 3.3). 
 
Figure 3.3.  Analysis of collagen alignment using SHG images.  An eccentricity value closer to 0 suggests normal 
collagen structure, and a value closer to 1 suggests collagen fibers with a preferred orientation.  Boxed area in the 
upper image is a representative example illustrating the size of the small SHG images below.  FT stands for Fourier 
transform [96]. 
 The alignment analysis was performed on all animals in all three groups, as shown in 
Figure 3.4a.  In the non-wounded with rMuIL-12 group, no noticeable collagen contraction was 
observed except on day 1, which was most likely caused by hair removal (Fig. 3.4b).  Both of the 
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wounded groups showed changes in collagen alignment during the healing process with peaks 
around day 14, which can be seen in both the Fourier transform of the SHG images (Fig. 3.4a) and 
the longitudinal tracking of collagen alignment (Fig. 3.4b).  One-way ANOVA combined with 
Tukey HSD test revealed that both of the wounded groups showed a significant increase (p<0.05) 
in collagen alignment on day 14 compared to the non-wounded group (Fig. 3.4b).  This result could 
suggest that both of the wounded groups showed a significant increase in collagen contraction on 
day 14, which would be understandable since collagen contraction often follows collagen synthesis 
and accounts for up to a 40% decrease in wound size [13, 53].   
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Figure 3.4.  2D FT shows the change in collagen alignment during wound healing.  (a) Representative SHG and 2D 
spatial FT images from each experimental group on selected imaging days.  (b) Longitudinal tracking of collagen 
alignment/orientation during the one-month study period.  † Both wounded groups show significantly higher 
alignment compared to the non-wounded group on day 14 (p<0.05).  * In the wounded group with placebo injection, 
the level of collagen alignment is significantly higher on day 14 compared to days 2, 7, and 28 (p<0.05).  Scale bar: 
30 m applies to all [96]. 
In addition, both wounded groups exhibited large variations in the level of collagen 
alignment since differences in wound healing rates are expected among different animals.  Also, 
the collagen fibers around wound can experience different levels of collagen contraction, which 
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can be observed in Figure 3.2.  Furthermore, volumetric SHG data throughout a depth of 
approximately 80 mm of the wounded skin was also acquired to investigate potential changes in 
collagen structures across different depths.  The results showed that there were no observable 
changes in the collagen structure at deeper layers of the dermis, such phenomenon cannot be 
investigated due to the limit of penetration depth and the loss of SHG signals with increasing depth. 
Looking at the dynamic trend of collagen alignment in each experimental group, it was 
found that the level of collagen alignment on day 14 was significantly higher compared to 
days 2, 7, and 28 in the wounded group with placebo injection (Fig. 3.4).  However, similar 
differences were not observed in the wounded group with rMuIL-12 injection.  While these results 
may imply that there was a more drastic change in collagen organization in the placebo group 
during healing, additional studies are necessary to make further conclusions.  IL-12 is known to 
induce the production of IFN-, which is one of the effectors of matrix synthesis regulation [52, 
91].  In addition, the release of IFN-g interacts with macrophages, whose main functions include 
matrix synthesis [52].  Therefore, injection of rMuIL-12 in the wounded mice at the early time 
point of wound healing can potentially have an effect on the progression of healing.  Although 
additional conclusions cannot be made based on current observations, our results show the 
heterogeneity of the microenvironment of the wounded skin, and the unique capability of SHG for 
evaluating the process of collagen regeneration and reorganization.  In future studies, additional 
SHG parameters, such as the polarization of the collagen fibers, should also be characterized to 
further understand the relationship between IL-12 and the process of matrix synthesis. 
3.2.5 FLIM imaging of the effect of rMuIL-12 on the metabolic activity in wounded skin 
FLIM generates image contrast between different excited-state lifetimes characterized by various 
fluorescence decay rates of the endogenous fluorophores in tissue [71], and it was used in the study 
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to examine the effect of rMuIL-12 on the metabolic activities in the skin around the wound bed 
during healing.  Figure 3.4a shows representative FLIM images from each experimental group on 
days 0 (pre-wounding), 2 (24 hours post injection), 3 (48 hours post injection), and 14. 
 The imaging plane was focused on keratinocytes approximately 2-6 m deep below stratum 
corneum layer in the epidermis, where NADH is the dominant fluorophores and changes in 
metabolic activity in the skin can be evaluated based on the change in the fluorescence lifetime 
[39, 50, 100].  Results demonstrated that no significant changes in fluorescence lifetime was 
observed in the non-wounded group.  In both wounded groups, elevation in the fluorescence 
lifetime was seen after wounding and injection (blue-shift in Fig. 3.5a), however, only the 
wounded group that received the rMuIL-12 injection showed a significant increase (p<0.05) than 
the wounded group with placebo injection on day 2, which was 24 hours post wounding and 
injection.  In addition, the wounded group that received the rMuIL-12 injection demonstrated 
significantly longer fluorescence lifetime (p<0.05) than the non-wounded group at the 48-hour 
time point after injection (day 3).  These observations suggested that only the wounded group 
receiving the rMuIL-12 injection demonstrated a significant increase in metabolic activity during 
the early time points of wound healing since an increase in fluorescence lifetime suggests an 
increase in the cellular metabolic activity [72, 101].  In addition, the results of the cross-group 
comparison suggested that the wounded group with rMuIL-12 injection showed a faster metabolic 
response toward the wound compared to the other wounded group  They also suggested that only 
the wounded group with rMuIL-12 injection had a significantly larger metabolic response 
compared to the non-wounded group during the early time point of the wound healing. 
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Figure 3.5. Dynamics of the metabolic activity in the wounded skin during healing using FLIM.  (a) Representative 
FLIM images from each experimental group on selected days.  (b) Longitudinal tracking of the change in fluorescence 
lifetime during wound healing.  ‡ Wounded with rMuIL-12 group has a significantly longer lifetime compared to the 
wounded with placebo group on day 2 (p<0.05).  † Wounded group with rMuIL-12 injection has a significantly longer 
lifetime compared to the non-wounded group on day 3 (p<0.05).  * In the wounded with rMuIL-12 group, the lifetimes 
on days 2 and 3 were significantly longer than day 0 (p<0.05).  Scale bar: 20 m applies to all [96]. 
 One of the first responses of an organism to pathogens is an inflammatory reaction, which is 
also an important phase during wound healing that will then lead to tissue repair [53, 91].  During 
the healing process, there is an increase in energy demand that results in an increase in metabolic 
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rate in wounded skin [102], which was demonstrated by both of the wounded groups in the study.  
Longer fluorescence lifetime suggests that there is an increase amount of the protein-bound 
NADH, which is the long lifetime component of NADH [59, 72].  The protein-bound NADH is 
associated with oxidative phosphorylation [103], the oxygen-mediated metabolic pathway that is 
more efficient in energy production in the biological system [104, 105].  The significant increase 
in fluorescence lifetime we observed in the wounded group that received the rMuIL-12 suggested 
that the additional IL-12 administration post wounding initiated a significant increase in metabolic 
rate through the process of oxidative phosphorylation to satisfy the higher demand for energy in 
the healing skin.  Our results suggest that IL-12 triggered a greater and more rapid inflammatory 
response after wounding, which is potentially associated with the significant increase in the 
metabolic rate.  These phenomena may be beneficial to the overall process of wound healing. 
 Preliminary results from this study showed that IL-12 induced a significantly more rapid onset 
and higher metabolic activity in the wounded skin during the early time points of wound healing.  
In addition, it appeared that the additional administration of this pro-inflammatory cytokine 
initiated a stronger inflammatory response that may be beneficial to the overall progression of skin 
wound healing, and may very likely play a key role in protecting the biological system against 
radiation damage.  SHG results showed signs that could imply that the wounded mice with IL-12 
injection showed a less drastic change in collagen structure during healing, but additional studies 
are needed to verify this observation and to make further conclusions about the effect of IL-12 on 
matrix synthesis or possible correlations with the significant increase in metabolic activity.  While 
additional investigations are required, including the dynamic profiles of the immune cells and 
changes in wound healing progression in radiation-damaged skin, this study demonstrated the 
complex nature of wound healing and the need for multimodal imaging technology that can offer 
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quantitative, non-invasive longitudinal tracking of cell and tissue dynamics at the cellular-level 
resolution.  We can then better comprehend the complex mode of action of IL-12, and the 
corresponding cellular dynamics in respond to this cytokine. 
 One significant limitation encountered in this study involved the field of view of FLIM.  It was 
difficult to identify the imaging location of FLIM relative to the wound because it took 
approximately 2 minutes to acquire a 120 x 120 m2 area.  With this speed, it would be unrealistic 
to acquire a FLIM image with the same field of view as SHG mosaic, which covered an area of 
approximately 2 x 2 mm2.  Due to this reason, it was difficult to make additional biological 
conclusions regarding the metabolic environment around the wound, and its possible linkage to 
collagen regeneration.  Another limitation of this study was the lack of vasculature information.  It 
was challenging to perform reliable OCT vasculature imaging on the dorsal skin of mouse largely 
due to breathing artifacts.  Nevertheless, this study demonstrated multiphoton microscopy as a 
potentially powerful tool to investigate the mechanisms of cytokine treatment at the cellular level.  
While the impact of IL-12 on radiation-damaged skin was not directly studied in this study, MPM 
imaging illustrated that this compound has an early impact on the cellular environment.  This 
imaging technology provided an in vivo imaging resolution unparalleled by standard visual 
observation, and may provide cellular information that would help researchers understand the 
mechanisms of IL-12 on ameliorating radiation damages on skin. 
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CHAPTER 4: EFFICACY OF STEM CELL TREATMENT FOR 
NON-HEALING DIABETIC WOUNDS  
The research presented in this chapter focuses on characterizing the efficacy and mechanisms of 
some of the novel treatments recently developed for non-healing diabetic wounds.  Diabetes causes 
many physiological complications, including non-healing wounds.  While many research has 
focused on understanding the cause of non-healing wounds and developing therapeutics for 
treating the wounds, a better understanding of the tissue microenvironment of non-healing wounds 
and the in vivo mechanisms of novel treatments are needed to significantly improve future 
pharmacological development.  The study presented in the chapter involves evaluation of adipose- 
and muscle-derived stem cells.  Multimodal microscope was utilized to observe the mouse skin, 
and image analysis methods were developed to quantify the biological activities in wounded skin.  
The results presented here may provide more direct ways of monitoring patient response toward 
the treatments in the future. 
4.1 Non-healing diabetic wounds and stem cell treatment 
In recent years, over 29 million American adults were diagnosed with diabetes, with Type 2 
diabetes accounting for 90 to 95% of all cases [5].  Insulin resistance and subsequent elevation of 
blood glucose can result in generation of reactive oxygen species and advanced glycation end 
products that destroy proteins necessary for vessel and nerve structure and function [106].  
Microvessel and nerve damage provide the basis for the majority of chronic diseases and 
conditions associated with Type 2 diabetes, including cardiovascular and kidney diseases, 
retinopathy, glaucoma, peripheral neuropathy, and impaired skin wound healing [9]. 
The content of this Chapter was based on reference [120]: Li J, et al, J. Biomed. Opt. (2016), with permission from SPIE. 
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 Impaired skin wound healing is a significant comorbid condition of diabetes.  Diabetes-induced 
peripheral neuropathy results in an increased number of skin lesions that can progress to non-
healing ulcers, mainly because of poor peripheral microcirculation, often leading to non-traumatic 
lower-limb amputations [107].  Therefore, there is a critical need to better understand the 
microscopic cell, tissue, and microvascular changes that occur in these non-healing wounds and 
seek appropriate treatment for them. 
 As discussed previously, wound healing is a dynamic, interactive process that typically consists 
of three major phases overlapping in time [13, 52].  During the inflammation phase, inflammatory 
cells including neutrophils and macrophages are recruited to the wound site to phagocytose the 
bacteria and dead cells to prepare the wound for healing [13, 54].  Fibroblast migration and 
proliferation predominates the second phase, which also includes synthesis of collagen necessary 
for tissue repair, re-epithelialization of the epidermis, angiogenesis, and myofibroblast-mediated 
wound contraction and closure [53, 54].  During the tissue remodeling phase, the deposition of 
extracellular matrix (ECM) takes place with appropriate collagen abundance and alignment [13, 
53].  Under diabetic conditions, changes in the immune response, including excessive neutrophil 
and macrophage influx, can disrupt the normal wound healing process [108].  In addition, 
abnormalities in the microvasculature often disrupt cell transportation and communication, 
causing complications in other wound healing events such as re-epithelialization and collagen 
formation [109]. 
The stromal vascular fraction of homogenized adipose tissue is enriched in stem cells that have 
the capacity to accelerate repair of non-healing skin wounds [110-113], including a heterogeneous 
mixture of cell types such as endothelial progenitor cells, adipose-derived stem-stromal cells 
(ADSCs, predominantly mesenchymal stem-stromal cells), and pericytes.  While the healing 
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capacity of these cells may differ according to the specific cell type isolated from adipose and 
donor characteristics, such as body mass index, health status, and age [113-116], studies suggest 
that ADSCs exhibit high potential for treating skin wounds in diabetic rodent models [110-113].  
Due to their ability to differentiate into various cell lineages, they have been shown to possess the 
potential for epithelial differentiation, which leads to accelerated re-epithelialization [112].  In 
addition, ADSCs have also been shown to have the capacity of differentiation into endothelial cells 
and secretion of angiogenic growth factors that contribute to neovascularization [112].  The extent 
to which stem cells from other tissues, including muscle-derived stem cells (MDSCs), exhibit a 
similar capacity for wound healing is an active area of investigation.  Previous studies suggest 
MDSCs have great potential for the regeneration and repair of muscle, bone, and cartilage due to 
their ability of differentiation into different cell lineages [117].  However, their potential for 
contributing to healing mechanisms as a cell therapy for wound healing have not been thoroughly 
evaluated. 
 In this study, a multimodal microscopy system was utilized to assess the efficiency of stem cell 
treatment for non-healing diabetic wounds.  Results yielded in vivo relationship between 
administered stem cells and location collagen fibers that would be difficult to be visualized with 
traditional fluorescence microscopy.  This study illustrated the potential of multimodal MPM as a 
screening tool for evaluation of novel treatments. 
4.2 Evaluation of adipose- and muscle-derived stem cells  
The effectiveness of the regeneration of ADSCs and MDSCs was assessed using an integrated 
multimodal microscopy system equipped with TPF and SHG imaging, which allowed monitoring 
in vivo changes in the collagen network and cell dynamics in a skin wound. 
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4.2.1 Stem cell preparation and study design 
Stem cell isolation and fluorescence-activated cell sorting 
Stem cell isolation was performed under a laminar flow hood using sterile technique as previously 
reported [118].  Excised epididymal fat pads or gastrocnemius-soleus complexes were extensively 
minced in phosphate-buffered saline (PBS) and subjected to enzymatic digestions in 0.2% Type 1 
collagenase for 45 minutes with repeated trituration.  After adding the inhibition solution (20% 
fetal bovine serum (FBS) in Hank’s balanced salt solution (HBSS)), the samples were spun for 
5 minutes at 450g and filtered through a 70-m strainer.  The cells were then blocked with 
antimouse CD16/CD32 antibody for 10 minutes on ice to prevent nonspecific Fc receptor-
mediated binding.  Following the blocking step, cells were incubated with a fluorescent-conjugated 
antibody cocktail (Anti Sca-1-PE, 600 ng/106 cells and anti-CD45-APC, 300 ng/106 cells) diluted 
in 2% FBS in PBS for one hour on lice, followed by two washes in 2% FBS in PBS.  Fluorescence-
activated cell sorting (FACS) was performed on an iCyt Reflection System and Sca 1+CD45- cells 
were collected in growth media (DMEM, 10% FBS, 5 g/mL gentamycin). 
Stem cell labeling and injection 
FACS-isolated adipose- or muscle-derived Sca 1+CD45- cells were seeded on 100 mm plastic 
culture dishes (106 cells) and the growth media was changed every 3 to 4 days.  MDSCs were 
previously characterized as Pax7-CD31-CD34- cells with multilineage potential [119].  After 8 
days, cells were incubated for 10 minutes at 37C with 5-mL StemPro Accutase Cell Dissociation 
Reagent.  Equal volume of growth media was then added to stop the dissociation reagent and cells 
were subjected to low speed centrifugation (5 minutes at 450g).  The supernatant was discarded 
and the pellet was resuspended in 1-mL serum-free media (high glucose DMEM).  Cells were then 
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incubated for 20 minutes with 5-L Vybrant KiI cell-labeling solution at 37C in the dark, 
followed by three washes with serum-free media.  Cells were then resuspended in HBSS at 106 
cells per 1 mL and were introduced into the wound perimeter using repeated subdermal injection 
(100 L, 9104 to 105 cells per wound).  The skin around the wound site usually “bubbled up” 
after injection, which was an indication that cell suspension had been introduced. 
Wounding and imaging procedures 
Both diabetic mice (male BKS.Cg-Dock7m +/+ Leprdb/J (db/db), n=18) and wild type (male 
C57BL/6 WT, n=18) were subjected to treatment evaluation.  Each type of mouse was divided to 
three subgroups (6 mice/group): no treatment (saline injection), ADSCs treatment, and MDSCs 
treatment.  Before imaging, skin preparation and wounding were performed under anesthesia 
(1.5% isofluorane gas mixed with 2% oxygen).  Hair on the lower dorsal skin was first shaved 
with electric clipper, and the remaining hair in the region was further removed under a surgical 
microscope using surgical tweezers.  The shaved skin was then cleaned with rubbing alcohol, and 
full thickness excisional wounds were made using a sterile 1 mm biopsy punch.  The wounded 
skin was then gently cleaned with rubbing alcohol. 
 Two of the six mice in each group were randomly chosen to be imaged using the multimodal 
microscopy on days 0 (after wounding), 1, 2, 4, and 8.  The saline/stem cell injections were 
performed on day 0 after imaging, and the wounds were covered with Tegaderm and surgical gauze 
to minimize animal scratching and photobleaching of the DiI-labeled cells.  In addition to the 
microscope imaging, standard photographs of the wounds on all animals were acquired on each 
imaging day for comparison. 
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Imaging acquisition and processing 
TPF and SHG images of the wounded skin were acquired concurrently with image dimensions of 
approximately 2 x 2 mm2 using a motorized stage to scan in the lateral dimensions.  The position 
of the laser beam relative to the skin wound was used as a reference to ensure that the wound site 
and the same area of skin were captured within the same field-of-view during scanning each day.  
Large-area images were assembled as mosaics of 10 x 10 individual images that were stitched 
together in post-processing using Matlab and ImageJ.  TPF and SHG images were overlaid using 
ImageJ. 
Wound size and collagen remodeling measurements 
The size of wounds was measured in ImageJ from the photographs captured with a surgical 
microscope on each imaging day.  The percent of wound closure was calculated by dividing the 
change in wound size compared to the initial wound size (day 0) by the initial wound size. 
 To calculate the percent of collagen remodeling, segmentation of the SHG collagen images was 
performed using Matlab.  Each SHG image was first converted to a binary image utilizing Otsu’s 
method, and the wound bed and its area in each binary image can then be identified and measured.  
The percent of collagen remodeling was calculated using the same method as the percent of wound 
closure described above. 
Statistical analysis 
All data are presented as means  standard error (SE).  Wound healing dynamics (changes in 
wound size based on photographs) were first evaluated for WT mice, and then repeated for diabetic 
mice.  Two-way repeated measures ANOVA (5 x 3) were used to investigate main and combined 
effects of time and treatment on wound size, followed by Fisher’s least significant differences post 
hoc analysis.  Statistical analysis was performed using SPSS Ver. 20.  Differences were considered 
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significant at p  0.05.  In addition, a nonparametric test was performed using Friedman’s test 
coupled with multiple comparison analysis, and the result was comparable to that from two-way 
repeated ANOVA. 
4.2.2 Effect of treatment in WT mice 
Good healing was observed in all three groups, as shown in Figure 4.1, and the area of skin that 
was considered part of the wound was identified with dashed lines in the photographs.  However, 
a better healing trend was observed in cell-treated groups compared to the saline treatment group 
(Fig. 4.1b), and the percent wound closure of both treated groups was significantly higher than the 
saline group on day 2. 
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Figure 4.1. Wound size comparison across all treatment groups in WT mice. (a) Representative photographs of the 
wounded skin in each treatment group.  Area of the skin that is considered part of the wound was identified by dashed 
line.  Scale bar: 1 mm applies to all photos.  (b) Comparison of the percent of wound closure measured from the 
photographs (n=6).  *On day 2, the percentage wound closure of saline group was significantly lower than both 
ADSCs-treated group (p0.01) and MDSCs-treated group (p0.05) [120]. 
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Figure 4.2. Comparison of collagen remodeling and dynamic movement of stem cells in all three groups of WT mice.  
(a) Representative composite MPM images of the collagen matrix (SHG, blue), and the DiI-labeled stem cells (TPF, 
red) of the wounded skin in each treatment group on days 0, 2, 4, and 8.  Scale bar: 200 m applies to all.  (b) 
Comparison of the percentage collagen remodeling calculated using the SHG images (n=2, solid dot: animal #1; 
hollow dot: animal #2).  Both treated groups showed slightly faster rate of collagen remodeling compared to the control 
[120]. 
Two of the 6 animals in each group were randomly chosen for imaging utilizing the MPM system.  
Composite images of SHG and TPF illustrate the progression of collagen remodeling (SHG) and 
the localization of ADSCs and MDSCs (TPF) during the course of study (Fig. 4.2).  Collagen 
matrix remodeling was observed in all three treatment groups.  However, a more organized 
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collagen network, consisting of stronger SHG signals as well as a “basket-weave” structural 
organization associated with normal skin [52], was readily apparent in the stem-cell treated groups 
compared to the saline control groups (Fig. 4.2a).  A collagen network with the “basket-weave” 
structure would be mechanically stronger and provide better structural support than a collagen 
network without this type of structure [52].   
This observation was most evident on days 4 and 8, as both treated groups demonstrated visible 
collagen contraction around the wound bed.  In addition, the TPF fluorescence signal from stem 
cells was visible in both treated groups, and ADSCs and MDSCs appeared to remain close to the 
edge and center of the wound during most of the healing.  Finally, the rate of healing was assessed 
by quantifying the percent of collagen remodeling.  The rate of collagen remodeling in the wound 
was slightly faster in both treated groups compared to the saline controls, shown by the faster rise 
of dynamic trend (Fig. 4.2b).  The MPM results reflect a similar trend as wound closure 
measurements obtained by traditional photography (Fig. 4.1b), but offering additional new high-
resolution subsurface visualization of the collagen network. 
4.2.3 Effect of treatment in diabetic (db/db) mice 
Db/db mice were also randomly divided into three groups and received the same treatments as WT 
mice.  As observed in the photographs of the wounded skin, the wound size increased in db/db 
mice without treatment (control) on days 2 and 4, and the skin around the wound bed appeared to 
deteriorate with skin reddening (Fig. 4.3a).  In contrast, both treated groups showed a progressive 
decrease in the wound size (Fig. 4.3a).  The percent of wound closure was also calculated.  One 
day following treatment (day 1), the average wound size was significantly smaller in the group 
treated with MDSCs compared to the saline group (Fig. 4.3b, p0.05).  Wound size was 
significantly smaller in both treated groups two days post-treatment (Fig. 4.4b, p0.05 for ADSCs 
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and p0.01 for MDSCs), and remained smaller 4 and 8 days post-treatment (Fig. 4.3b, p0.01 for 
both treated groups). 
 
Figure 4.3. Wound size comparison across all treatment groups in db/db mice.  (a) Representative photographs of the 
wounds in each group.  Area of the skin considered as part of the wound was identified by dashed lines.  Scale 
bar:1 mm applies to all.  (b) Comparison of the percent of wound closure from all three groups measured from the 
photographs (n=6, meanSE).  *On day 1, the percent wound closure of non-treated group was significantly lower 
than MDSCs-treated group (p0.05).  **On day 2, the percent wound closure of non-treated group was significantly 
lower than both treated groups (p0.05 for ADSCs; p0.01 for MDSCs).  ***On days 4 and 8, the percent wound 
closure of non-treated group was significantly lower than both treated groups (p0.01) [120]. 
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 Two of the 6 animals from each group were randomly selected for imaging with the MPM 
system.  While the non-treated diabetic mice exhibited increased wound size during the first 4 
days, immediate and progressive healing was observed in the stem cell-treated groups (Fig. 4.4).  
TPF signal was recorded inside the wound bed in both treated groups (Fig. 4.4a).  Stem cells 
appeared to be localized to the center of the wound bed. 
 
Figure 4.4. Comparison of collagen remodeling and dynamic movement of stem cells in all three groups of db/db 
mice.  (a) Representative composite MPM images of the collagen matrix and the DiI-labeled stem cells of the wounded 
skin in each treatment group.  Scale bar: 200 m applies to all.  (b) Comparison of the percentage collagen remodeling.  
Both treated groups showed noticeably faster rate of remodeling compared to non-treated group.  The non-treated 
group showed an increase in wound size during the study, and there were minimal changes in size on day 8 compared 
to day 0 [120]. 
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Quantitative data obtained from the MPM images (Fig. 4.4b) reflected comparative results from 
the photographs (Fig. 4.4b).  However, it appeared that the collagen matrix remodeled at a slower 
rate than the actual wound closure.  In addition, by further comparing the photographs and the 
SHG images, it was observed that the darker and reddened skin around the edge of wounds, seen 
in the photographs, corresponds to areas with minimal or no collagen signal.  This observation is 
shown in Figure 4.5, which again emphasizes the importance of having subsurface information to 
fully understand the condition of the healing skin. 
 
Figure 4.5. Overlay of the standard photograph and SHG image from the non-treated mouse on day 4, which shows 
the lack of SHG signals in the reddened skin seen in the photograph (blue arrow).  Scale bar: 500 m [120]. 
 Closer examination of the wound bed revealed co-localization of fluorescently labeled stem 
cells with collagen fibril network in both WT and db/db mice (representative image for db/db 
mouse shown in Figure 4.6, indicated with arrows.  The observation suggests the capacity for stem 
cells to attach to and/or remodel the ECM.  In addition, Figure 4.6 shows that MPM imaging 
provides the level of in vivo subsurface details of the skin microenvironment that cannot be 
observed in standard photographs. 
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Figure 4.6. Microscopic visualization of collagen network remodeling and cellular dynamics in treated db/db mice.  
In the SHG and TPF images acquired at the area indicated in the photograph (black box), locations where visible co-
localization of collagen fibers and stem cells were identified (green arrows in MPM images).  Scale bar: photograph: 
250 m; MPM: 50 m [120]. 
 In conclusion, both ADSCs and MDSCs exhibited remarkable and equivalent capacity to repair 
diabetic wounds, likely due to their ability to synthesize and replace multiple growth, angiogenic, 
ad immunomodulatory factors deficient in the diabetic wound bed.  The application of a 
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multimodal MPM imaging system for the assessment of wound repair revealed interesting insight 
regarding stem cell localization and influence on structural remodeling at the site of injury.  These 
results provide further justification for stem cell-based therapeutics and the potential of MPM for 
assessment of wound healing in diabetic patients.  The use of traditional histology for visualizing 
and evaluating the process of wound healing is significantly limited given the complexity of 
cellular events within the skin microenvironment.  Recent advances in optical microscopy 
technologies, such as the reflectance microscopy or CLSM, provided increased capacity for 
imaging cell dynamics in skin during normal or pathological conditions [121, 122].  However, 
these imaging modalities do not typically provide both spatial and temporal co-registration in a 
multimodal imaging setting.  A solution to this challenge has been to develop an integrated 
multimodal microscope that combines the various mechanisms of physical contrast from cells and 
tissues as well as to implement registration algorithms to longitudinally track cell, tissue and 
microvascular dynamics in skin injury and regeneration over weeks to months [35]. 
 It is clear from both photographic and MPM images that diabetic mice treated with stem cells 
exhibited significantly faster wound closure rates than mice that did not receive treatment.  While 
standard photography captured the process of wound closure, it did not provide the microscopic 
subsurface information necessary to reveal stem cell localization or the impact of the stem cells on 
the surrounding environment.  The example comparison of photographic and MPM images in 
Figure 4.6 shows the level of in vivo resolution in MPM images that photography cannot offer.  
Co-registration of the SHG and TPF channels allows visualization of thin collagen fibers on the 
edge of the wound bed, as well as the individual stem cells that interact with the collagen fibers.  
This observation could suggest that the stem cells applied to the wounded skin anchored into these 
loose collagen fibers to migrate or to communicate with the host cells, or that the stem cells were 
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directly involved in collagen remodeling at the edge of the wound [123, 124].  The relationship 
between these stem cells and collagen remodeling during healing should be further investigated 
and explored, and larger imaging size is needed in future studies to achieve higher statistical power, 
and to evaluate the reliability of this imaging technology in assessing wound treatments. 
 Impaired diabetic wound healing is the accumulated result of numerous complications and 
abnormalities, including decreased collagen synthesis and insufficient neovascularization.  These 
two processes are heavily dependent on each other since the ECM provides the tissue foundation 
for vascularization, and newly formed vessels deliver the oxygen and nutrients necessary for the 
healing process [13, 125].  The mechanism by which the stem cells facilitated collagen synthesis 
in not entirely clear, but stem cells are endowed with the capacity to synthesize both ECM proteins 
and metalloproteinases necessary for active tissue remodeling [109, 126].  The contribution of 
topically applied stem cells to ECM turnover may provide the basis for the improved collagen 
remodeling observed in the MPM images.  A strong collagen network that was actively contracting 
around the wound bed was clearly evident in stem cell-treated mice, including WT mice that 
appeared to heal effectively based on photographic images.  Although not directly assessed, it is 
possible that enhancement of collagen remodeling and structure provides the basis for protection 
from further damage and-or long-term scarring.  Therefore, stem cell administration may be 
advantageous for healthy individuals, as well as individuals in which endogenous stem cell 
migration and function may be lacking. 
 While including TPF and SHG was useful in understanding the effect of stem cell treatments 
on collagen remodeling, one crucial information missing was vasculature regeneration.  Stem cell 
treatments have shown remarkable wound healing ability, including improving vasculogenesis 
[127].  Unfortunately, this mechanism cannot be monitored in this study because reliable PV-OCT 
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vasculature images cannot be acquired from the dorsal skin of mice largely due to breathing 
artifacts.  Additional information regarding the relationship among the administered stem cells, 
collagen, and vasculature structure can be elucidated by including spatially co-registered images 
that include all the above skin components.  With this knowledge, the mechanisms of adipose- and 
muscle-derived stem cells on wound repair can be better understood. 
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CHAPTER 5: HEALING MECHANISMS OF AN 
ANGIOGENESIS-PROMOTING TOPICAL TREATMENT  
Similar to the previous chapter, Chapter 5 also focuses novel treatments designed for non-healing 
diabetic wounds.  However, this chapter addresses a different aspect of diabetic wounds, which is 
the relationship between angiogenesis and non-healing diabetic wounds.  To characterize the 
angiogenesis process during healing and the corresponding metabolic activity, an angiogenesis-
promoting topical treatment for diabetic wound, designed by pharmaceutical company, 
GalxoSmithKline, was investigated.  The topical treatment promotes angiogenesis by mimicking 
a hypoxic environment via inhibition of prolyl hydroxylase resulting in elevation or maintenance 
of hypoxia-inducible factors, and its effect on the wound microenvironment was evaluated using 
the PV-OCT and FLIM imaging modalities of the multimodal microscope system.  PV-OCT was 
utilized to capture the structure of the vasculature network, and FLIM was used to track the 
metabolic activity in cells. 
5.1 Angiogenesis in diabetic wound healing 
Another important step during wound healing is angiogenesis, which has a crucial role in many 
diseases and physiological responses.  In wounds, capillary injury creates a hypoxic environment, 
triggering the release of essential growth factors and cells to participate in neovasculogenesis and 
angiogenesis, a process that is often dysfunctional in diabetic wounds [13, 15, 94, 128].  One 
transcription factor that is closely related to angiogenesis and wound healing is hypoxia-inducible 
factors (HIFs).  Regions of hypoxia are common during wound healing, and the low level of 
oxygen inhibits prolyl hydroxylase, which stabilizes the HIF-1 protein [129, 130].  HIF-1 can 
then transactivates a repertoire of genes facilitating metabolic and angiogenic pathways to adapt 
The content of this Chapter was based on reference [136]: Li J, et al, J. Biophotonics (2017), with permission from John 
Wiley and Sons. 
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hypoxia, leading to wound re-epithelialization and healing [128-130].  Figure 5.1 describes the 
process of HIF-1 induction. [130]. 
 
Figure 5.1. Induction of HIF-1 target genes by hypoxia.  Adapted from [130] with permission from Springer Nature. 
  Promising advances have been made in the development of therapies for non-healing diabetic 
wounds [131, 132].  However, most analyses and assessments of wound healing have been 
completed using visual observation, standard photography, in vitro cell work, and histology.  
While these techniques offer invaluable information, the in vivo environment is more complicated, 
and it can be difficult to infer how a specific type of treatment will affect the microenvironment of 
the skin as a whole based solely on in vitro cell studies.  In addition, due to the limited resolution 
of the photographs, a wound may appear “closed and healed,” but the underlying collagen 
structures or vasculature networks are not fully remodeled.  A surface-closed wound without a 
proper collagen structure underneath does not offer the same mechanical integrity as non-wounded 
skin and can be prone to further damage in the future.  To address these issue, a technology capable 
of noninvasive, in vivo monitoring of wound healing with cellular-level resolution will provide a 
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better understanding of this complex process, and the effect of treatments on different parts of the 
healing process in a natural environment.  In recent years, several optical imaging techniques have 
proven beneficial in observing key biological events, both in vivo and ex vivo, including OCT, 
CLSM, hyperspectral imaging, and MPM [77, 96, 133-135].  These imaging techniques have 
provided both structural information and the healing dynamics of wounds at a scale that cannot 
always be obtained from visual observation and histology.  The additional information acquired 
by these imaging modalities may offer new insights into the dynamics in wounded skin, and benefit 
future development of treatments. 
5.2 Experimental design 
Male BKS.Cg-Dock7m +/+ Leprdb/J (db/db) diabetic mice were used as the animal model.  The 
ear skin was chosen as a wounding site since it was less affected by breathing motion, and readily 
allowed for the observation of microvasculature regeneration and the effect of the topical cream.  
Ear skin preparation and wounding were performed under anesthesia (1/5% isofluorane gas mixed 
with 2% oxygen) using a surgical microscope.  Hair on the right ear skin was removed with surgical 
tweezers to reduce possible autofluorescent signals from the skin hair.  The skin was then cleaned 
with rubbing alcohol, and a full thickness excisional wound, which included the entire layer of 
skin on top of the cartilage of the ear, was made using a sterile 1-mm biopsy punch.  It is important 
to note that the ears were not pierced completely through during the wounding process.  The skin 
was then gently cleaned again with rubbing alcohol. 
 Two groups of animals, treated and placebo, were involved in this study, and both the 
angiogenesis-promoting topical formulation and the placebo (drug vehicle only), were prepared 
and provided by GlaxoSmithKline.  The treatment group (n=5) received daily application of the 
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angiogenesis-promoting ointment for 14 days, and the placebo group (n=5) received daily 
application of the placebo vehicle for 14 days.  On day 0 of the study, both multimodal microscope 
images and digital photographs of non-wounded skin from all animals were acquired.  All animals 
were wounded on day 1, followed by microscopy imaging and digital photographing, and then the 
respective treatments were applied to the wounds of the designated animal group.  Longitudinal 
in vivo multimodal imaging of the wounds from both groups was performed under anesthesia on 
days 1, 3, 7, 10, 14, 21, and 28.  On all imaging days, the mouse sear was carefully mounted to 
minimize the amount of motion artifact due to breathing, which can greatly affect the quality of 
the vascular imaging.  During the treatment period (days 1-14), the treatments were applied each 
day after imaging and photographing.  The wounds were left uncovered, and no analgesics or 
additional agents were administered to the mice during the course of the study. 
5.3 Image and statistical analysis 
All vessel analyses from the PV-OCT images were performed utilizing Matlab.  Three different 
parameters were quantified to evaluate the angiogenesis-promoting effect of the active agent: 
overall vessel density, vessel branching point density, and mean vessel diameter.  The rationale 
for choosing these three parameters is discussed in the next section.  PV-OCT images were first 
processed using contrast-limited adaptive histogram equalization in Matlab to enhance contrast, 
and then filtered using a medium filter.  The filtered images were then segmented using Otsu’s 
method to obtain binary images of the vessel structures for all subsequent analyses. 
 To determine the overall vessel density, the total number of segmented vessel pixels in the 
binary images was divided by the total image area (in pixels), excluding the signal-free wound 
area.  Vessel branching points were calculated by first skeletonizing the binarized vessel image, 
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and then identifying all the vessel connecting points.  Following this, the number of connecting 
points was divided by the total image area, excluding the signal-free wound area.  To determine 
the mean vessel diameter, the binary image of the vessels was first skeletonized to identify the 
midline of each vessel.  The distance between the midline and the vessel boundary (radius) at all 
points were then calculated, and the vessel diameters at all locations were obtained by multiplying 
these acquired radii by 2.  The mean vessel diameter across the entire image was then calculated 
by dividing the sum of the vessel diameters from all locations by the number of identified vessel 
diameters. 
 FLIM analysis was performed using SPCImage software (Becker-Hickl).  The biexponential 
fluorescence decay model was fit to the recorded data set at each pixel to acquire the 4 parameters 
used for comparison in this study: mean fluorescence lifetime, relative ratio of protein-bound 
NADH to free NADH, fluorescence lifetime of protein-bound NADH, and fluorescence lifetime 
of free NADH.  In addition, the value at each pixel, which indicates the goodness of fit of the 
fluorescence decay curve at each pixel, was used to identify the pixels with poor fits to the decay 
curve.  The data from these pixels were then discarded and not included in the analysis. 
 All data are represented as meansSE.  two-way repeated measures ANOVA (8x2) were used 
to investigate main and combined effects of time and treatment, followed by Fisher’s least 
significant difference post hoc analysis.  Statistical analysis was performed using Matlab, and 
differences were considered significant at p0.05. 
5.4 Regeneration of the microvasculature network 
The ear skin was chosen as a wound model due to the ease of access to the microvascular network.  
During each imaging session, the mouse ear was carefully positioned to ensure the entire wound 
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was within the field-of view during scanning.  Figure 5.2 illustrates the PV-OCT images of both 
treatment and placebo groups on selected days to show the changes in the microvasculature 
network during healing.  It should be noted that due to the relatively thin skin on the mouse ear 
and impractical wound coverage options, the ear wounds on all mice became full-thickness holes 
after approximately one week.  However, this was consistent across all animals, and the 
morphological changes in the wound skin could still be monitored.  Visual comparison between 
the two groups shows a noticeably denser vessel network around the edges of the healing wounds 
in the treated group, compared to the placebo group (Fig. 5.2a). 
 
Figure 5.2. PV-OCT and vessel analysis shows that the treatment group experienced a higher level of angiogenesis 
during healing.  (a) PV-OCT images of both treatment and placebo groups.  (b) Analysis shows a significantly higher 
vessel density in the treatment group.  (c) Treatment group has a significant increase in branching point density. 
(d) Treatment group experienced a decrease in vessel diameter.  *Treatment group has significantly higher/lower 
values than placebo group (p0.05).  Scale bar: 500 m applies to all [136]. 
 To confirm this visual observation, overall vessel density was calculated.  The results in 
Figure 5.2b show that the overall vessel density in the treatment group was significantly higher 
(p0.05) than in the placebo group during treatment.  During the early stages of wound healing, 
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the angiogenesis process produces additional microvessels to increase the efficiency of oxygen 
and nutrient delivery, and to sustain newly formed tissue.  This process usually ceases after the re-
epithelialization and granulation tissue formation stage, which often lasts for approximately 
10 days [13]. 
 
Figure 5.3. PV-OCT images illustrating the presence of larger vessels in deeper layers of the skin (circled in yellow).  
Comparison with Figure 4.8 shows that these are the same large vessels observed in days 1 and 7 in the treatment 
group.  Scale bar: 500 m applies to all. 
 To investigate whether the increase in overall vessel density observed previously was caused 
by an increase in angiogenesis or an enlargement of vessel diameters, both the vessel branching 
point density and the average vessel diameter parameters were calculated.  Results show that the 
treatment group experienced an increase in branching point density in the first week after 
wounding, which was significantly higher than the placebo group (Fig. 5.2c).  This suggests that 
the treatment group experienced an increase in angiogenesis during the early stage of wound 
healing.  In contrast, the placebo group showed a gradual decrease in branching point density after 
wounding.  In additional, further investigation of the volumetric PV-OCT dataset showed a 
noticeable increase in the amount of small vessels in the superficial layers of the skin in the 
treatment group, which overshadowed some of the larger vessels that are visible in days 1 and 7 
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but not in later days (Fig. 5.2a).  Figure 5.3 illustrates the presence of these larger vessels in the 
deeper layers of the volumetric dataset. 
 To quantify the change in vessel diameters during the study period, the mean vessel diameter 
on each day was calculated, as shown in Figure 5.2d.  Both groups showed some variation in 
diameter during the healing process.  However, only the treatment group showed a notable 
decrease in mean diameter during the first week of healing, which is significantly lower than the 
placebo group during treatment.  This decrease in mean vessel diameter and increase in branching 
point density in the treatment group could suggest an increase in the number of smaller vessels, 
which is expected during the early stage of angiogenesis [137].  Comparison across these 
parameters suggested a correlation between the increase in vessel density and the increase in vessel 
branching in the treated group. 
5.5 Identification of hypoxia in keratinocytes 
The area of the skin surrounding each wound was imaged using FLIM each imaging day to assess 
the effect of the topical cream on the cellular metabolic activity in the skin.  For each animal, after 
the OCT vasculature image was acquired, regions around the wound bed were selected for FLIM 
imaging (Fig. 5.4).  Representative FLIM imaging of both treatment and placebo groups are shown 
in Figure 5.5a, and a color scale representing the fluorescence lifetime range is included.  Clear 
visual differences can be seen in the FLIM images between the two groups.  It is evident from the 
FLIM images that the treatment group had a larger representation of lower lifetime components 
(red hues) during the treatment period (Fig. 5.5a) than do the controls. 
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Figure 5.4. Composite image of skin structure and vasculature OCT with selected regions of FLIM imaging. 
 
Figure 5.5. FLIM analysis shows that the treatment group experienced a hypoxic reaction during the drug application 
period.  (a) FLIM images of the treatment group have more red hues during the treatment period.  (b) The mean NADH 
fluorescence lifetime in the treatment group is significantly shorter than in the placebo group.  (c) Ratio of protein-
bound and free NADH is also significantly lower in the treated mice.  (d) Treatment group has significantly shorter 
protein-bound NADH excited state lifetimes.  (e) Treatment group shows significantly shorter free NADH excited 
state lifetimes on day 3.  *Treatment group has significantly smaller values than placebo group (p0.05).  Scale 
bar: 20 m applies to all [136]. 
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 Results show that the treatment group had a shorter lifetime during the course of topical 
application (days 1-14), while the placebo group experienced an increase in mean lifetime during 
healing (m, Fig. 5.5b), which has been previously observed in wounded skin [96, 102].  In 
addition, statistical analysis showed that the mean lifetime in the treatment group was significantly 
lower (p0.05) than the placebo group during treatment period.  A decrease in mean fluorescence 
lifetime is usually caused by the presence of more short lifetime components (free NADH) than 
long lifetime components (protein-bound NADH), which suggests a metabolic shift from oxidative 
phosphorylation toward glycolysis [72].  To further investigate the cause of the decrease mean 
NADH lifetime in the treatment group, additional parameters were calculated.  The ratio of protein 
bound NADH and free NADH components (a2/a1) was calculated each day to examine changes in 
the relative concentrations of the two components.  Figure 5.5c shows that the bound-to-free 
NADH ratio in the treatment group was significantly lower than the placebo group, suggesting that 
there was an increased level of glycolysis, which is often observed under hypoxic condition and 
supports an HIF induction related switch to glycolytic mechanisms consistent with prolyl 
hydroxylase inhibition [71, 72, 138]. 
 In addition, differences between the treatment and placebo groups during the treatment period 
were also found between bound (2) and free (1) NADH lifetimes, as illustrated in Figure 5.5d 
and e.  The treatment group had a significantly lower bound NADH lifetime than placebo on 
certain days (Fig. 5.5d), which can be explained by NADH binding to shorter lifetime enzymes or 
proteins, causing the bound NADH lifetime to decrease [71].  The free NADH lifetimes in both 
groups had similar trends throughout the study, except for a decrease in the treatment group on 
day 3, which had also been previously observed under hypoxic condition [72].  This analysis shows 
that the decrease in mean NADH lifetime in Figure 5.5a is caused by the decreases in the bound-
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to-free NADH ratio, the bound NADH lifetime and the free NADH lifetime.  All of these 
observations suggest that there was an increase in glycolysis in the wounded skin treated with the 
active agent, which was consistent with a hypoxic environment [71, 72]. 
 Although FLIM has been shown by previous studies as a reliable imaging tool to characterize 
hypoxia in living tissue, future studies should also include additional methods that can directly 
measure the oxygenation level in tissue.  One possible technique involves injecting phosphorescent 
light-emitting complexes into the wound.  Such imaging probes emit phosphorescence under 
hypoxia due to oxygen quenching, and have been utilized for imaging tumor hypoxia [139].  
Another method that would be a good addition is NIR spectroscopy, which is a label-free technique 
that directly measures the optical absorption of hemoglobin under different oxygen levels.  It has 
been repeated proven as a reliable noninvasive technique to measure oxygenation in different types 
of tissue, including muscles, brain tissue, and tumor [140-142].  In addition, the light source 
required for NIR spectroscopy is compatible with the laser source utilized in the multimodal 
microscope system, and therefore would be a good addition that requires minimal modifications 
of the current system.  Both techniques above will be the most reliable and direct way of assessing 
oxygenation in tissue without adding excessive complexity to the imaging system. 
To conclude this section, with the expected rise of diabetes in the general population an active 
area of research has been in developing treatment strategies for non-healing diabetic wounds.  
Understanding the healing mechanisms of novel treatments is also an essential part of drug and 
therapy development.  Multimodal microscopy enables label-free, and more direct way to observe 
and quantify microvascular and metabolic healing mechanisms, and the biological response to a 
topical treatment.  This advancement is relevant due to the limited ability to assess wound 
physiology or treatment effects in patients with chronic wounds or delayed healing.  The type of 
74 
 
cross-modality correlation presented here, combined with quantitative image analysis can follow 
the morphologic, microvascular and metabolic changes in the wound healing process in ways not 
possible with many current evaluations.  The insights demonstrated by this technology could lead 
to new noninvasive endpoints for evaluation of the efficacy of new therapeutics in environments 
that do not permit traditional assessments, and lead to more direct ways of detecting personalized 
patient responses to treatment. 
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CHAPTER 6: HIGH-SPEED MULTIMODAL MULTIPHOTON 
AND OPTICAL COHERENCE MICROSCOPY 
This chapter focuses on the development of a video-rate multimodal microscopy system.  Details 
of the microscope development are presented here, including challenges involving combining 
optical coherence microscopy with the video-rate multiphoton microscopy system.  The 
motivation of designing a high-speed multimodal system and its application to biomedical imaging 
are also discussed in this chapter. 
6.1 Motivation 
The first-generation multimodal microscopy system introduced in previous chapters has provided 
immense information relating to the skin microenvironment of various types of diseases.  
However, the studies presented in the previous chapters also elucidate a critical limitation of the 
system, which is the acquisition speed.  The scanning mechanism utilized in the first-generation 
microscope involves a pair of galvanometer (galvo) mirrors, which is inherently slower in speed 
compared to other types of scanning mirrors, such as a resonant scanning mirror.  While the 
previous system can acquire a large field-of-view (FOV) TPF-SHG images in a reasonable amount 
of time (approximately 8 minutes for a 10 x 10 mosaic), it was proven challenging to capture short-
term time-lapse dynamics over large tissue volume, which limited our ability to characterize the 
global dynamics in living tissue.  In addition, since the previous microscope utilized TCSPC 
detection system for FLIM imaging, the acquisition speed for this modality was very slow – a 
128 x 128-pixel image took approximately 2 minutes to acquire.  Due to this speed limitation, it 
was impractical to achieve spatial co-registration of FLIM with TPF-SHG at large FOV, and 
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provided challenges to collect information that may be useful in understanding the relationship 
between the chemical environment in the skin and cell activities in the local regions.   
Therefore, it was necessary to design an imaging system that can achieve significantly faster 
imaging speed to allow large FOV imaging in all modalities, and to perform better cross-modality 
correlation from the same imaging region.  This high-speed imaging system was designed to 
include two components: multiphoton microscopy that includes TPF, SHG, and FLIM, and a time 
domain OCM. 
6.2 Video-rate multimodal multiphoton microscopy 
6.2.1 Fluorescence lifetime microscopy 
The development of the video-rate microscope began with the FLIM modality, which was 
originally developed for imaging the fast dynamics that occur following the onset of apoptosis, or 
programmed cell death [143-145].  While conventional FLIM imaging can achieve high-sensitivity 
and yield abundant information of the metabolic state of tissue, the use of TCSPC for NADH 
metabolic imaging has a fundamental speed restriction currently requiring pixel dwell time 
potentially on the order of 100 s, limiting the possibility of imaging fast dynamic that occurs on 
a shorter time scale [146]. 
 To achieve a faster scanning and detection rate, the scanning mirror for the fast axis was 
switched to an 8 kHz resonant mirror (EOPC SC-30 PLD-1s).  After the signal was collected by 
the PMT (Hamamatsu H10721-20), it is sent through a high bandwidth transimpedance amplifier 
and directly digitized using a 12-bit, 1.8 gigasamples per second digitizer (AlazarTech ATS-9360) 
[143].  Figure 6.1 below shows the high-speed FLIM system design and characterization. 
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Figure 6.1. FLIM system design and characterization.  (a) System schematic.  (b) Representative fluorescence decay 
curves from standard fluorescent dyes.  (c) FLIM image of SHG signal from a urea crystal giving a measure of the 
response function of the system.  Scale bar: approximately 10 m.  abbreviations: BS, beam splitter; PD, photodiode; 
M, mirror; RM, resonant mirror; GM, galvo mirror; TL, tube lens; DM, dichroic mirror; OL, objective lens; S, sample; 
PMT, photomultiplier tube.  Adapted with permission from [143], Optical Society of America. 
  One of the challenges of this high-speed imaging system is the data analysis.  Due to the 
relatively few temporal data points combined with wide response function of the analog PMT, the 
conventional curve-fitting procedure for reconstructing the biexponential decay function is not 
effective.  Instead, the data are directly fit from the peak response to a single exponential model, 
as has been performed in similar systems [147].  As a result, this FLIM system is capable of 
achieving an imaging speed of approximately 20 frames per second, which is roughly 2500 times 
faster than the first-generation microscope while still maintaining enough temporal resolution to 
distinguish metabolic dynamics.  Figure 6.2 below illustrates a 1 x 1-mm in vivo FLIM imaging 
of a wound on the mouse dorsal skin.  This image was acquired under 3 minutes with an 80-frame 
average at each stage position to achieve optimal contrast and high signal-to-noise ratio decay 
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measurement.  A FLIM image with this same FOV may take up to hours to acquire utilizing the 
TCSPC detection system. 
 
Figure 6.2. In vivo FLIM imaging of a wound on the mouse dorsal skin.  Scale bar: 150 m. 
 Figure 6.2 provides a global view of the metabolic state of the wounded skin at a scale that 
cannot be achieved utilizing the first-generation system.  The image shows clear cellular features 
of the keratinocytes in the region further away from the wound edge (Fig. 6.2, lower left corner).  
It also illustrates the difference in NADH lifetime between region further away from the wound 
edge and area around the wound edge.   
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6.2.2 Dual-detection two-photon excited fluorescence and second harmonic generation 
microscopy 
After the FLIM modality was completed, TPF and SHG modalities were still needed to resume the 
type of multimodal imaging offered by the first-generation microscope [90].  Similar to the 
previous configuration, a simultaneous dual-detection setup was developed to ensure perfect 
spatial co-registration between TPF and SHG.  A schematic of the detection arm is shown in 
Figure 6.3. 
 
Figure 6.3. Schematic of the imaging head of dual-detection TPF and SHG.  TPF signal is detected by PMT 1 and 
SHG is detected by PMT 2.  Abbreviations: L, lens; DM, dichroic mirror; O, objective. 
 Dual-channel TPF and SHG was operated at the 920 nm wavelength to achieve optical 
excitation of SHG and GFP fluorophore, which will be discussed in details in later chapter.  The 
MPM signal that is generated at the focus was collected by a high-NA objective (Olympus 
XLPLN-25X-WMP2—1.05 NA; 25× magnification) and deflected by a dichroic mirror.  An 
additional dichroic mirror splits the MPM signal into two separate channels each containing an 
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interchangeable emission filter and analog PMT.  The setup described above can achieve nearly 
perfect co-registration of TPF, SHG, and FLIM.  Although minute position shifts at the pixel level 
may occur due to wavelength changes between TPF-SHG (920 nm) and FLIM (750 nm), it does 
not have a significant effect on the precision of the co-registration. 
 The signal photocurrents from each PMT were amplified by transimpedance amplifiers and 
sampled using the same high-speed digitizer used for the FLIM imaging.  Each channel was 
digitized simultaneously at 800 megasamples per second. Images were constructed by averaging 
multiple samples recorded for each pixel and written directly to a high-speed solid state drive to 
avoid memory bottlenecks limiting maximum recording duration. This allows seamless dual-
channel image acquisition at video-rate speeds.  
6.3 Time domain optical coherence microscopy 
The other part of the high-speed multimodal microscopy design was to incorporate a phase-
sensitive OCT/OCM in order to obtain vasculature information of the living skin.  The first-
generation multimodal microscope incorporated spectral domain OCT/OCM, however, due to the 
significant increase in speed of the scanning mirrors, the line scan camera utilized in the spectral 
domain system was not suitable.  Therefore, a high-speed en face time domain configuration 
coupled with a single photodiode detector was implemented. 
6.3.1 En face optical coherence microscopy 
En face OCT/OCM relies on the same principle as time domain (TD) OCT.  However, instead of 
having a movable mirror in the reference arm that changes the optical path length, en face OCT 
modulates the path length of light in the reference arm through acousto-optic modulators (AOM) 
to achieve heterodyne detection and capture the complex backscattered field from the sample [84, 
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148].  As is typical in TD-OCT systems, interference fringes are measured as a function of time, 
therefore, high-speed photodiodes are commonly employed as opposed to spectrometers as in 
spectral domain (SD) OCT. 
 Another large distinction of en face OCT is the choice of interferometer.  Instead of using a 
traditional Michelson interferometer as in SD-OCT and TD-OCT, a Mach-Zehnder interferometer 
was utilized, where sample and reference beams are guided in separate arms [149, 150].  This type 
of interferometer was chosen because the AOMs implemented in this system are in single-pass 
mode, and the double-pass light path in a Michelson setup would negate the effect of the AOMs.  
The design used in this thesis is shown in Figure 6.4 below. 
 
Figure 6.4. Schematic of multimodal MPM and en face OCM.  Abbreviations: PBS, polarized beam splitter; 
M, mirror; L, lens; PCF, photonic crystal fiber; BS, beam splitter; DG, diffraction grating; LSC, line scan camera; 
PD, photodetector; AOM, acousto-optic modulators; DM, dichroic mirror; O, objective. 
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In the reference arm, two AOMs (1205C, Isomet) were implemented to change the optical path 
length in the reference beam.  The first AOM shifts the light by 80 MHz (AOM 1), while the 
second AOM has a tunable frequency and was set to approximately 81 MHz (AOM 2).  This 
resulted in a final path-length modulation of approximately 1 MHz when compared to the sample 
arm light.  The sample arm of the system shared the same beam path and objective as MPM, as 
illustrated in Figure 6.4 above.  In addition, a crystal identical to the ones used in the AOMs in the 
reference arm was placed in the sample arm for dispersion compensation.  The crystal was 
necessary because the crystals in the two AOMs present in the reference arm produced a large 
amount of dispersion, which broadened the axial point-spread function of the system.  It was a 
slightly defective crystal given by the company, which was originally manufactured for the 1205C 
AOM (Isomet).  Thus, a double-pass through this crystal matched the dispersion introduced by the 
two AOMs in the reference arm.  The sample and reference arms were combined by a 50:50 beam 
splitter and routed to an amplified photodiode (ThorLabs PDB450A) unit.  In addition to the 
en face OCT setup, an SD-OCT setup was also implemented for optical alignment and manual 
correction of dispersion with glass.  To switch from en face OCT to SD-OCT, the flip mirror 
illustrated in Figure 6.4 was utilized, which re-directed the light to a custom-built spectrometer.  
The sample arm of the setup was identical to that described in the MPM configuration in the 
previous section.  The objective of constructing this multimodal system is to develop a video-rate 
multimodal system capable of large FOV multimodal imaging to capture the dynamic activities 
involving cells, collagen, and microvasculature in the skin microenvironment. 
6.3.2 AOM modulation speed characterization and in vivo imaging 
As mentioned in the previous section, two AOMs were implemented in the reference arm to 
modulate the path length.  The first AOM shifts the light at a fixed frequency of 80 MHz, and the 
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second AOM has a tunable frequency.  To achieve optimal modulation frequency of the OCM 
system, it was important to determine the appropriate output frequency of the second AOM.  
Initially, the second AOM was set to shift the light in opposite direction by approximately 81 MHz 
to result a net modulation path-length of approximately 1 MHz according to the previous en face 
OCT system built in the laboratory [151].  Each en face OCM image was 256 x 256-pixel size, 
and was acquired at 1.6 gigasamples per second with 200 sample-average per pixel.  The acquired 
OCM data was processed utilizing envelope detection, which returns the envelopes of the input 
data giving the magnitude of the OCM signal.  Figure 6.5 below illustrates a representative B-scan 
from the first en face OCM scan of scattering beads.  Figure 6.5c also shows the magnitude of the 
OCM signal derived from envelope detection. 
Figure 6.5. First en face OCM image of scattering beads.  (a) OCM image of scattering beads. (b) Representative B-
scan from location marked in (a).  (c) Envelope detection method reveals the magnitude of the OCM signal, which is 
the blue envelope in (c).  This is a representative pixel scan over the range marked by two orange lines in (b). 
 The initial testing revealed that 1 MHz was not an optimal modulation rate, which produced a 
blurry OCM image of the scattering beads in Figure 6.5a.  A closer examination of the detected 
envelope of OCM signal shows that 1 MHz was insufficient to resolve a complete modulation 
cycle at each pixel, as shown by the blue envelope in Figure 6.5c, which was an incomplete 
sinusoid.  In other words, the frequency was too low to be captured by the fast digitization rate 
utilized in the system.   
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Additional calculation showed that because both the resonant scanner and the digitizer of this 
OCM system operated at a higher speed than the previous system, a higher path-length modulation 
in the reference arm was necessary.  To avoid previous problems, the output frequency of the 
second AOM was increased to 90 MHz, which produced a net path-length modulation of 10 MHz 
in the reference arm.  The same scattering beads were imaged again followed by the same 
processing method, and the resulting image was no longer blurry as shown in figure below. 
Figure 6.6. En face OCM image of the scattering beads at 10 MHz modulation frequency.  (a) OCM image of the 
beads.  (b) Representative B-scan at the location marked in (a).  (c) Representative pixel scan over the region marked 
by two orange lines in (b).  The blue envelope represents the magnitude of OCM signal. 
 The resulting OCM image was much clearer, with individual bead clearly identified.  In 
addition, the B-scan showed less background noises where no beads were present, and the Nyquist 
sampling was met.  From this test, 10 MHz modulation frequency was considered appropriate for 
future OCM imaging. 
 To make the system appropriate for animal imaging, the imaging stage was redesigned to be 
able to fit a mouse and the anesthesia tubes, as shown in Figure 6.7a.  A circular coverslip glass 
was place between the water-immersion objective and the animal.  In addition, a small drop of 
glycerol was place between the coverslip and the animal skin for index matching and better contact 
between the cover slip and the animal skin. 
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Figure 6.7b illustrates an in vivo image of the mouse skin acquired from the system.  This image 
was cropped from a 6 x 6 mosaic, which covered an area of approximately 1 x 1 mm2.  It was 
acquired at 30-frame average at each stage location, and the total acquisition time was 
approximately 80 seconds.  The OCM image showed clear structure of hair follicles and the nuclei 
of keratinocytes, especially at regions near the hair follicles. 
 
Figure 6.7. In vivo en face OCM imaging of mouse skin.  (a) Imaging stage showing the animal position.  (b) A large 
FOV OCM mosaic image of live mouse skin.  Scale bar: 80 m. 
 The penetration depth of the OCM system was also investigated using excised mouse skin.  To 
prepare the sample, a piece of 0.5 x 0.5 cm2 shaved skin was excised from a mouse post-mortem, 
and a 300-m thick skin sample was cut from it using a vibrotome.  The skin sample was then 
placed on a petri dish with glass bottom.  Small drop of saline was applied on top of tissue to 
prevent drying.  Starting from the depth where OCM signal first appeared, a 20-frame average was 
acquired at each depth with 5-m step size in axial direction, and the acquisition was stopped 
before the contrast was considered too poor for proper analysis. 
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Figure 6.8. En face OCM depth of field in excised skin.  (a) OCM image at each depth from 0 to 80 m (the last depth 
is not shown).  Clear collagen structure was clearly shown throughout, and the imaging was stopped before the contrast 
was considered too poor for analysis.  Scale bar: 60 m.  (b) 5 x 5 mosaic of the skin sample imaged for the depth 
test.  Scale bar: 100 m. 
 Figure 6.8 shows the OCM image at each depth and a large FOV mosaic of the skin sample, 
and the collagen structure can be clearly seen at all depths shown in Figure 6.8a.  Images were also 
acquired at depths 85, 90, and 95 m, but the OCM contrast was rather poor and may affect post-
processing analysis.  It was reasonable that the penetration depth of the system was shallow 
compared to standard OCT, considering that a high NA objective (1.05 NA) was utilized in the 
system.   
6.3.3 Characterization of motion sensitivity 
Speckle variance 
In order to perform vasculature imaging on skin, the system needs to have high sensitivity to blood 
flow.  The first approach was based on speckle-variance (SV) OCT because it was straightforward, 
and can be extracted directly from the OCT magnitude data.  It was observed during in vivo skin 
imaging that speckle flickering can been seen around hair follicles, which resembles blood flow 
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patterns seen previously [152].  The initial attempt to obtain image contrast in this manner was 
performed on mouse ear skin.  The mouse was mounted on the imaging stage according to the 
procedure described in the previous section, and 30 OCM frames were acquired at each stage 
location over a 5 x 5 mosaic FOV (approximately 800 x 500 m2) at 8 different depths with 3-m 
step size in axial direction.  Each image was processed using envelope detection technique as 
described previously, and the magnitude variance of 30 OCM frames at each stage location was 
calculated.  The mosaic images of both magnitude and speckle-variance at each imaging depth 
were assembled using MosaicJ in ImageJ using the same stitching parameters, and the variance 
from all imaging depths were projected axially to produce the final speckle-variance vasculature 
image. 
 
Figure 6.9. In vivo SV-OCM test in mouse ear skin.  Speckle variance images show blood vessel-appearing structures 
at some regions, as circled in the figure.  However, SV-OCM image appears very incomplete. 
 Selected SV-OCM images are shown in Figure 6.9.  Speckle flickering was observed in selected 
locations surrounding the hair follicles during the video-rate imaging, and many of these regions 
showed speckle variance signals that resemble blood vessel structure, as shown in Figure above.  
However, much of the speckle variance signals appeared to be due to tissue movement, and the 
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vasculature structures were mostly incomplete.  After repeated trials, it was determined that 
speckle variance was not sensitive enough in this system to capture blood flow in living skin. 
Phase variance 
To process the phase variance (PV) OCM signal, the envelope detection method used previously 
was not suitable since only the amplitude information can be extracted.  Therefore, a Hilbert 
transform technique was implemented to obtain both amplitude and phase information.  This 
technique required the data to be processed in the Fourier domain. In the frequency domain, it was 
observed that the OCM data acquired contains strong fixed-frequency noise.  This included the 80 
MHz laser pulse signal and noise generated from the sample clock [143], some of which can be 
easily removed in the Fourier domain.  The Hilbert transform processing involved first isolating 
the 10 MHz OCT interference signal by applying the Tukey window in the Fourier domain and 
shifting the signal to the DC followed by applying the inverse Fourier transform to retrieve the 
complex OCT signal.  Figure 6.10 below illustrate the flowchart of this process. 
 With this processing method, the system phase stability was measured using a USAF resolution 
target similar to the one shown in Figure 6.10e.  The phase stability test revealed that while the 
system was phase sensitive, significant phase wrapping was observed in the measurement, 
preventing accurate phase recovery.  It was discovered that the noise could be slightly reduced by 
decreasing both the sampling rate of the digitizer and the modulation frequency of AOM, though 
the origin of these noise sources were not successfully resolved.   
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Figure 6.10. En face OCM signal processing using Hilbert transform.  (a) Raw data of a B-scan from the location 
identified in (e).  (b) Fourier transform of (a), illustrating all major frequency peaks contained in the raw data.  Tukey 
window was applied over the region marked in orange.  (c) The isolated interference signal shifted back to DC.  
(d) Inverse Fourier transform of the shifted interference signal.  (e) OCM image of an USAF resolution target. 
Due to the noise problem, the sampling rate was decreased to 500 megasamples per second and 
the path-length modulation of AOM was decreased back to 1 MHz.  However, additional problems 
were discerned during this process.  The reconstructed OCM amplitude image revealed that the 
image was not clear and the structure appeared smeared.  Further analysis suggested that the 
problem was potentially associated with the AOM modulation frequency being too low for the 
speed of resonant scanning mirror and the Nyquist sampling was not met.  This observation could 
potentially lead to the system being unable to resolve spatial features.  In addition to the strong 
laser pulse signal and digitizer sampling signal observed in the Fourier domain of the OCM raw 
data, a weaker 10 MHz frequency noise was discovered, which was possibly the signal from the 
master clock that controls the resonant scanning mirror [143].  Therefore, the modulation 
frequency of AOM was changed to 16 MHz, which was fast enough to meet Nyquist sampling 
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without overlapping with frequency ranges where the noise sources were present.  Although this 
solution resolved the lateral resolution issue, the interference signal in the frequency domain was 
unstable and significantly weaker than the noise from laser pulse and digitizer signals.  Figure 6.11 
below shows these technical difficulties observed here. 
 
Figure 6.11.  OCM image of the scattering beads at 16 MHz modulation frequency and a B-scan in Fourier domain.  
The weak interference signal (orange) resulted in poor structural image, and was unlikely to generate reliable phase 
signal.  Important frequency signals were labeled in the plot, showing that the interference signal is significantly lower 
than most of the background noises. 
 In addition to a weak interference signal overall, the signal strength was also inconsistent across 
the image.  The interference signal was stronger at certain parts of the image, while the rest of the 
image was almost as weak as the baseline noise.  System alignment was repeatedly adjusted along 
with the stage position, but this problem was unable to be solved.  At this stage, it was not possible 
to acquire reliable phase information due to the weak interference signal.  It was determined that 
while the en face OCM system described in the section was capable of acquiring high-contrast 
OCM structural images, it did not have strong enough phase stability to serve as a platform for 
vasculature imaging. 
91 
 
6.4 Summary and future direction 
6.4.1 High-speed multiphoton microscopy 
The video-rate MPM system presented in this chapter demonstrated high potential as an imaging 
platform to evaluate certain biological phenomena, such as wound healing, in a brand new way.  
While numerous studies have been performed to observe the cellular dynamics in wounded skin, 
they often had to be done in a relatively small FOV, ex vivo environment, or on different animals 
to acquire longitudinal information [90, 153-155].  These constraints were partially due to 
technical difficulties, including imaging speed, and could significantly limit the amount of 
information that could be obtained from the skin microenvironment.  In this chapter, a video-rate 
multimodal MPM system was developed and shown to be capable of performing time-lapse 
imaging over a large region on the skin with a FOV unachievable previously.  Most importantly, 
it was capable of large FOV in vivo FLIM imaging, which is challenging using current methods.   
 This MPM system was further put to test in a multimodal cellular dynamics study that will be 
presented in the following chapter.  The abundant information offered by this system allow re-
examination of numerous biological phenomena in a new way, and can potentially provide 
additional knowledge related to the biological mechanisms behind these processes. 
6.4.2 En face OCT/OCM 
The implementation of an en face OCM system into the high-speed MPM proved more challenging 
than previously anticipated.  Though ultimately it was only reliable for structural imaging, 
insightful information was obtained, which was discussed here along with recommendations for 
future direction. 
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 The biggest challenge encountered involved having to integrate the OCM system into the 
already-built MPM system.  The Ti-Sapphire laser utilized in the system introduced several 
unwanted noise sources, including the 80 MHz pulse signal discussed previously.  In addition, 
because the FLIM modality required both the digitizer and resonant scanner to be synchronized 
with the laser source [143], the clocking system also introduced background noise in the OCM 
data.  All these major sources of noise added limitations to our AOM modulation frequency 
choices, as demonstrated in Section 6.3.  Most importantly, most of these noise sources were 
stronger than the interference signal, which significantly limited the system for sensitive 
measurement such as vasculature imaging.  Another challenge was related to the way the 
microscope was constructed, being built on open-table with long optical path length.  These 
conditions all potentially introduced instability to the phase measurement.   
 Going forward, I strongly suggest utilizing a continuous wave laser source for the OCM 
modality and redesigning the system as a dual-source multimodal microscope.  This approach can 
eliminate the need for a photonic crystal fiber, which can significantly simplify the OCM system 
and reduce power loss due to the crystal fiber.  In addition, fiber-coupling the laser beam is 
recommended, as it can greatly improve the phase stability of the system.  Although it can 
potentially result in loss of laser power, eliminating the use of photonic crystal fiber for 
supercontinuum will save a large amount of laser power to compensate for the loss from fiber-
coupling.  Alternatively, another suggestion is to redesign the multimodal system to significantly 
reduce the optical path length, specifically the sample arm length.  This can shorten the path length 
in the OCM reference arm, and potentially increase the phase stability of the system.  Furthermore, 
a minor suggestion is to use a slightly lower NA objective.  The current objective has an NA which 
may be too high for effective OCM imaging.  Using a slightly lower NA objective that will not 
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significantly sacrifice the lateral resolution of MPM may potentially achieve high-quality, spatially 
co-registered MPM-OCM imaging. 
 I believe it is possible to construct a high-speed multimodal MPM/OCM system, unfortunately 
the current microscope design included too many technical constraints for phase-sensitive OCM 
to be constructed effectively.  To further improve this multimodal system, it is recommended to 
consider the details presented in this thesis.  Having a video-rate multimodal MPM-OCM system 
will be incredibly powerful as it can provide multimodal MPM OCM information in both a 
temporally and spatially co-registered manner, allowing scientists and engineers to better 
understand the micro- and macroenvironment of many diseases. 
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CHAPTER 7: VIDEO-RATE MULTIMODAL MULTIPHOTON 
IMAGING AND 3D CELLULAR DYNAMICS 
CHARACTERIZATION  
This chapter outlines the development of a 3D multimodal analysis platform for cellular dynamics 
in skin.  As discussed previously, numerous studies have been done on understanding the complex 
environment of cellular dynamics in skin diseases, but few had attempted characterizing these 
cellular events under conditions similar to the native environment.  This involves longitudinal 
in vivo tracking of the same animals, temporally and spatially co-registered multimodal 
information from different constituents of skin, large imaging FOV, and an analysis platform that 
can combine all the different information together.  To address these issues, an analysis platform 
was developed to focus on 3D multimodal tracking.  Combining with the high-speed MPM system 
introduced in the previous chapter, the powerfulness and potentials of this approach was 
demonstrated in an in vivo wound healing study in mice.  Special attentions were focused on 
imaging techniques and biological parameters that cannot be accomplished with the previous 
imaging system and ex vivo analysis, including 3D cell tracking and co-registration of TPF, SHG, 
and FLIM.  The technology and results illustrated in this chapter opened new possibilities in ways 
pathological conditions can be evaluated, and can potentially provide new tools for 
characterization skin microenvironment and diseases in the future. 
7.1 Current technology in immune cell dynamics characterization 
The immune system is the most diffuse cellular system in the body, and all activities in this system 
are tightly regulated, including long-range cell migration, short-range communication by local 
chemical signaling and by cell-to-cell contacts [156].  Among different types of technology, the 
introduction of TPF into the field of immunology has been proven incredibly powerful due to its 
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ability to visualize time-lapse in vivo cell motility within native tissue environments [156].  In 
addition, the use of near-infrared wavelength excitation source also minimizes photodamages and 
photobleaching, and can achieve deeper penetration depth.  These characteristics are all ideal for 
long-term imaging deep into highly scattering tissue [157]. 
 Because multiphoton imaging can yield 4D information (x, y, z, t) of cell mobility and 
morphology, the very wealth of data permits researchers to characterize a variety of cellular 
dynamics parameters.  However, the amount of data generated often produced far more 
information than can be digested by human observers.  Therefore, reliable computation analysis 
tools can potentially take full advantage of the available data in an efficient and reproducible 
manner.  Numerous computational analysis platforms are available, including Matlab, ImageJ, and 
Cell Profiler, which are some of the well-known tools [158].  These tools allow researchers to 
characterize cell motility, including instantaneous and mean velocities, displacement, travel 
direction, etc. [156, 158-160].  Other parameters that can be quantified includes cell morphology, 
such as area, volume, and shape index [158, 159, 161].  Some more advanced morphology 
measurements is possible through decomposing the shape in terms of Zernike polynomials, or 
based on Fourier analysis, neural network, and principle component analysis [162-165].  All the 
cell parameters and analytical techniques have been widely used in characterizing cellular 
activities. 
 Another biological feature that has been heavily analyzed is collagen fiber structure.  As a tissue 
component that plays key role in the pathological state of skin diseases and cancerous tumors, 
numerous computational methods have been developed to characterize its fiber structure [77, 95, 
99, 166].  Some of the collagen parameters that have been heavily investigated include fiber angle, 
length, width, density, and curvature.  These parameters can be characterized computationally 
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mathematical models, such as Fourier analysis, and various computer-assisted image feature 
extraction methods, such as curvelet transform fiber extraction algorithm (CT-FIRE) [166].  
Among various techniques, CT-FIRE is especially powerful because it integrates transform-/filter-
based preprocessing techniques with fiber extraction methods to improve fiber extraction 
accuracy, which leads to high sensitivity toward change in collagen alignment. 
 To date, numerous computational analysis tools have been developed to quantify the 
multimodal cellular dynamics both at the molecular and cellular levels [160, 167-169].  However, 
few of the existing method specifically focus on integrating the multimodal information together 
in a temporally and spatially co-registered manner.  Most of the techniques focus on the cells 
exclusively in a relatively small FOV.  While the information obtained from these methods provide 
useful molecular and cell microenvironment information, these methods lack the ability to acquire 
information from the macroenvironment where coordinated events among different skin 
constituents can be better observed.  It is a universal understanding that cellular activities in living 
tissue is highly dynamic, and there is a need to develop imaging technology and computational 
analysis tool capable of quantifying the in vivo multimodal information in ways similar to the 
native environment. 
7.2 Development of 3D multimodal analysis platform 
To address the challenges discussed in the previous section.  A multimodal analysis platform was 
developed, which was designed to analyze time-lapse multimodal imaging data acquired by 
multiphoton microscope system similar to the one presented in the previous chapter.  This platform 
focused on characterizing 3D dataset in a spatially and temporally co-registered manner, which 
allows users to quantify the relationship between different skin constituents at any given time of 
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event.  In addition, this platform was designed with Matlab Graphical User Interfaces (GUI), 
allowing users to control selected parameters to optimize both image segmentation and tracking 
outcome.  Figure 7.1 below is a representative image of the multimodal analysis module developed 
in this study. 
 
Figure 7.1.  Representative image of the multimodal analysis module.  From the startup menu, user can select the 
analytical functions relevant to the study.  The information collected from individual module can be transferred to 
different analytical functions for cross-modality correlation. 
The goal of creating this type of point-and-click control applications was to provide an 
environment that can effectively utilize the unique and large amount of information offered by 
time-lapse in vivo multimodal multiphoton imaging.  Most importantly, another goal of this work 
is to encourage future researchers to change the ways pathological conditions are investigated. 
7.2.1 3D cell tracking 
One of the major part of this multimodal analysis platform is to perform 3D tracking of cell 
mobility.  This function is crucial because in vivo environment is highly dynamic, and 2D tracking 
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is not sufficient to fully quantify cellular activity.  In addition, breathing motion from the animal 
can minutely change the imaging depth during time-lapse imaging, and 3D tracking function will 
allow observers to follow single-cell movement as accurately as possible.  Figure 7.2 below shows 
the schematic of the 3D cell tracking module. 
 
Figure 7.2. Schematic of the 3D cell tracking module. 
 The first part of module involved optimizing the volumetric grayscale images of the TPF cell 
data.  By adjusting the values of minimum and maximum threshold values, user can optimize the 
contrast of the grayscale images and improve subsequent segmentation accuracy.  As shown in 
figure above, a slide bar was also incorporated below the grayscale image display to allow user to 
visualize different depths.  This part of the module also allowed user to identify specific time point 
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from the time-lapse data to optimize.  It was usually the starting time point of the time-lapse 
tracking later.  With the optimized volumetric data, the “image crop” function allowed user to crop 
the original image to isolate an area of interest for further analysis.  This function stored the 
cropped volumetric data and the x-y coordinates of the cropped location.  This information was 
important as it was utilized in other modules to quantify images from other modalities at the same 
location as where cells were tracked.  Next, cell segmentation procedure was performed on the 
cropped volumetric data.  Cell segmentation involved series of removing small objects from the 
binary file, filtering by object volume, and removing objects connected to the image borders.  As 
a last step, remaining connected components were identified and assigned with numerical 
numbers, and their 3D centroid coordinates were recorded.  These locations would serve as the 
initial time point of the time-lapse tracking at later step.  Again, a slide bar was incorporated to 
allow user to view different imaging depths, and it would record the depth information at the last 
location of the slide bar. 
 The depth information from the volume depth slide bar mentioned above were then imported 
into the “select cell” function.  This function generated a pop-up image of the cell at the imported 
depth and allowed user to click on cells to be tracked.  By comparing the 2D coordinates of the 
clicked locations to the 3D centroid coordinates of all objects identified previously, the correct 3D 
centroid coordinates of the selected cells were then located, and their corresponding numerical 
numbers (cell IDs) would be displayed, as shown in the figure above. 
 At this point, all the information required to perform 3D tracking was acquired.  As mentioned 
previously, the 3D centroid coordinates of the selected cells were used as the initial time point 
locations.  To perform 3D tracking of each cell, the Euclidean distances between the cell at current 
time point (t1) and all identified cells at the next time point (t2) were calculated.  The cell with the 
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smallest Euclidean distance was identified as the cell-of-interest at t2.  This procedure was repeated 
between all following adjacent time points until the final time point as indicated by the user.  When 
completed, this function would record the 3D centroid locations of all selected cells at all tracked 
time points.  With this information, the instantaneous velocity of all tracked cells would be plotted 
as shown in Figure 7.2.  In addition, user can use these coordinates to perform a variety of analysis, 
such as the travel direction of the selected cells.  When combining travel direction with other 
multimodal data, such as collagen and NADH lifetime, user can begin to correlate different 
multimodal information. 
7.2.2 Volumetric collagen structure characterization 
The second part of the analysis module involved SHG collagen characterization.  The goal was to 
design a platform that allowed collagen structure characterization at regions where tracked cells 
located, as identified previously in the cell tracking module.  Figure 7.3 shows the schematic of 
the collagen analysis module.  Although collagen was a 3D structure, all analyses performed in 
this module were in two dimensional because the way SHG images were collected lacked the 
cross-sectional details, and therefore, not ideal for 3D analysis. 
 This module started with opening the volumetric SHG data and allowed user to optimize image 
contrast. Which is similar to the 3D tracking module.  In addition, this function automatically 
cropped the original volumetric SHG data according to the cropping parameters recorded 
previously in the 3D tracking module.  This function also included a slide bar function that allowed 
user to view collagen images at different depths.  The “create SHG tiles” function further cropped 
smaller SHG regions based on the initial locations of the tracked cells, and saved each of the 
created small SHG images in a subfolder.  Because the multimodal data is three dimensional, it 
was crucial that each 2D SHG collagen image was retrieved from the same depth as the associated 
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cell.  To meet this goal, a 200 by 200-pixel SHG image was created centering around the associated 
tracked cell based on the 3D centroid coordinates.  By utilizing the z-direction of the centroid 
coordinates, SHG analysis can be performed at the same depth as the associated cell. 
 
Figure 7.3.  Schematic of SHG collagen analysis module.  Brief descriptions were included for selected functions. 
 After sub-region SHG image tiles were created, user can then execute the CT-FIRE collagen 
analysis tool on each of the created SHG image tiles.  Through CT-FIRE, selected individual 
collagen fibers were identified, and the orientation angle of each collagen fiber was calculated.  
Figure 7.4 below is a representative SHG image processed by CT-FIRE. 
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Figure 7.4.  Cell-based regional SHG image tiles created by the “create SHG tiles” function and analyzed images 
using CT-FIRE.  Selected individual collagen fibers were identified and the associated orientation angles can be 
calculated.  The blank region at the lower left corner in the left image was associated with the inside of the wound. 
 The last function involved in this module was the Fourier analysis of the same cell-based 
regional SHG image tiles.  This function is similar to the one described previously in Section 3.2.4, 
which provided information of the regional collagen alignment and orientation.  With the collagen 
parameters collected in this module, user can correlate them back to cell parameters and potentially 
quantify the relationship between collagen structure and cell motility. 
7.2.3 Area-based NADH lifetime analysis 
The last module was designed to perform area-based NADH lifetime analysis on large FOV FLIM 
images.  As discussed in previous chapter, the large FOV FLIM acquired from the video-rate FLIM 
provided information in the macroenvironment unavailable in TCSPC detection.  To effectively 
utilize these information, the purpose of this module was to allow user to perform overall NADH 
lifetime calculation and to characterize regional area-based NADH lifetime.  Figure 7.5 below 
illustrates the schematic of the analysis module. 
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Figure 7.5.  Schematic of area-based NADH lifetime analysis module.  This module performed both large FOV 
analysis and selected regional calculation. 
 In this module, both the NADH intensity and lifetime data were imported, and FLIM analysis 
involved only 2D data since FLIM was usually acquired at a single depth at the epidermal layer.  
Two types of lifetime calculation can be performed.  The first one utilized the cropping parameters 
stored from the 3D tracking module and calculated the mean NADH lifetime of the entire area, 
and the other one allowed user to select any areas in the entire image and calculated the regional 
lifetime.  The incorporation of area-based analysis provided user the freedom to analyze areas 
outside the TPF-SHG analysis region.  The information acquired here may provide clues on how 
regional metabolic states affected cell motility and collagen structure.  By combining multimodal 
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parameters quantified in both temporally and spatially co-registered manner, additional 
information may be collected regarding the biological conditions of living tissue, and the way 
cellular activity was orchestrated in their native environment. 
7.3 Video-rate multimodal MPM imaging and quantification of cellular 
dynamics in wounded skin 
To demonstrate the advantage of utilizing high-speed multimodal microscopy and the associated 
analysis platform to characterize in vivo cellular activities, an in vivo imaging study was performed 
on live mice.  This section details the experimental procedures, how the multimodal analysis 
platform was utilized, and the uniqueness that set these imaging and analysis techniques apart from 
conventional methods. 
7.3.1 In vivo multimodal volumetric imaging 
Animal model and preparation 
This study was designed to focus on the immune cell dynamics because this group of cells plays 
essential roles in all skin diseases and conditions discussed in this dissertation.  In addition, 
immune cell activities were highly dynamic and provided challenges in both imaging and post-
processing analysis, which would be a suitable example to demonstrate the powerfulness of the 
high-speed multimodal imaging and analysis combination presented in this chapter. 
 The animal model chosen for the study was female MacGreen B6N.Cg-Tg(Csf1r-
EGFP)1Hume/J transgenic mice (Jackson Laboratory).  These mice express enhanced GFP 
(EGFP) in peritoneal, bone marrow-derived, and broncho/alveolar lavage macrophages, as well as 
Langerhans cells.  Unlike other GFP-expressed transgenic mouse model, MacGreen model 
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expresses GFP specifically in macrophages, and therefore, an ideal model for immune cell 
dynamics study.  
 To prepare for imaging, the hair on the dorsal skin was carefully removed with surgical forceps 
and an electric shaver under general anesthesia (1.3% isofluorane, 1.3% oxygen) to reduce 
autofluorescence during imaging.  To wound the animals under anesthesia, the shaded skin was 
first cleaned with rubbing alcohol; afterwards, a full thickness wound was created using a sterile 
1-mm biopsy punch followed by additional cleaning with rubbing alcohol.  The wounds were left 
uncovered, and no analgesic compounds were prescribed to the animals during the study. 
Imaging procedures 
Since the focus of the study was on immune cell dynamics, the animals were image on days 0, 1, 
2, 3, and 7, and the animals were wounded on day 1 prior imaging.  On each imaging day, a 60-
minute TPF-SHG time-lapse was captured over 6 x 6 x 5 volumetric mosaic with 20-frame average 
per stage location, 5-minute time gap, 150-m lateral step size, and 5-m axial step size.  A 5-
minute time gap was used because continuous scanning can easily cause tissue burning by the 
laser.  Shorter time gas was not possible because acquiring and saving the data size mentioned 
above required approximately 5 minutes.  Although shorter time gap would be more ideal for 
capturing cell motility, one of the objectives of this study was to test the limit of high-speed time-
lapse imaging.  Therefore, large imaging volume with slightly longer time gap was chosen instead 
of small imaging volume with shorter time gap.  It is important to mention that the 5–minute time 
gap did not affect the 3D cell tracking significantly.  This volumetric mosaic covered a region of 
approximately 1000 x 1000 x 20-m volume.  This size was able to capture activities in a 
significantly large volume compared to the previous time-lapse study in Chapter 3 – the volume 
covered was only approximately 500 x 500 x 45 m2.  Regarding the imaging volume for TPF-
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SHG imaging, although the lateral dimension is significantly larger than the axial dimension, it is 
still considered three-dimensional from a technological perspective because the axial dimension is 
more than 10 times larger than the axial resolution of two-photon microscopy.  It is true that 
biologically, it is not the best representation of 3D region.  However, axial movement of the cells 
was observed and quantified during analysis.  Such movement would be difficult to characterize 
without the 3D tracking method described previously.  More importantly, rapid breathing artifacts 
were observed during imaging, but the cell movement can still be captured because of the 3D 
tracking module.  Therefore, although the axial dimension of the time-lapse imaging described in 
this chapter was relatively small, it was still a type of 3D tracking of cell dynamics because 
individual cell activity can be captured even when axial movement was present.  It is also important 
to note that the imaging system is capable of larger axial dimensions, but the focus of this study 
was on large-area coverage of the lateral movement of the cells around the wound bed without 
losing a significant amount of time-lapse information.  Therefore, the above imaging volume was 
chosen for the study.  In addition, a 6 x 6 FLIM mosaic with 80-frame average per stage location 
was also acquired, which covered the same lateral dimension as the time-lapse imaging (1000 x 
1000 m2) to ensure spatially co-registered TPF-SHG-FLIM.  FLIM acquisition in this study took 
approximately 3 minutes, which normally would take at least 2 hours using traditional TCSPC 
detection.   
All post-processing of images was done in Matlab and ImageJ to prepare the data for 
multimodal analysis later.  To assemble the time-lapse data into a format that can easily processed 
in the analysis platform, the TPF-SHG time-lapse data was re-organized into 2 modality channels 
with 5 depth slices and 13 time frames using the hyperstack function in ImageJ.  The hyperstack 
data was then saved as image sequence files, which labeled individual images with the associated 
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channel number, depth number, and time point.  The file identifiers mentioned here were later used 
in the analysis platform to differentiate individual time-lapse images. 
7.3.2 3D multimodal characterization of cellular dynamics 
To demonstrate the uniqueness of the multimodal analysis platform described in Section 7.2, 
emphasis of the image analysis was on identifying parameters and biological phenomena that were 
difficult to characterize using traditional techniques.  The study described in the above section 
generated a large amount of data.  It included movement of the macrophages and the associated 
collagen structure near the edge of wound, and NADH lifetime of the same region.  Figure 7.6 
below illustrates representative co-registered TPF-SHG-FLIM images that show the vast amount 
of information embedded in the data. 
 
Figure 7.6.  Representative of spatially co-registered in vivo TPF-SHG-FLIM images.  Left: TPF-SHG composite.  
Green represents GFP-labeled cells and blue represents collagen.  Right: FLIM NADH lifetime.  Scale bar: 200 m. 
This data set represented the first spatially co-registered TPF-SHG-FLIM images of living skin 
with an extended FOV.  Though the FLIM acquisition in this study took significantly less time 
than TCSPC detection, both the spatial and temporal resolution of the FLIM images collected in 
this study were sufficient to illustrate clear cellular structure of keratinocytes and allow accurate 
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NADH lifetime measurement at each pixel.  Although a variety of biological parameters were 
available to be characterized in this data set, the focus of this study was on the relationship among 
cellular motility and orientation, collagen fiber alignment, and NADH lifetime.  Since the objective 
of this imaging study was to demonstrate the effectiveness of the imaging and analysis techniques 
presented in this chapter, neither significant biological conclusions nor detailed implications were 
presented in this study. 
Immune cell motility, collagen orientation, and NADH lifetime distribution 
The first part of analysis was on 3D cell motility and orientation in living skin.  The imaging data 
characterized in this study was days 1 and 7 because these two data sets presented interesting visual 
differences.  In the time-lapse data on day 1, noticeable influx of the GFP cells toward the edge of 
wound was visualized.  In addition, the corresponding FLIM image showed that the NADH 
lifetime around the edge of wound appeared to be noticeable longer than the rest of the surrounding 
skin in the distance.  In comparison, the data set from day 7 did not show the same visual 
differences.  Figure 7.7 below shows the visual differences between the two imaging days.  In 
addition, the change in cell population over time was calculated using the information provided by 
the 3D cell tracking module.  Results illustrated that the day 1 data set showed a noticeable increase 
in cell population over time (Fig. 7.7c), which is consistent with visual observation.  The 
instantaneous velocity of the time-lapse data was also generated, shown in Figure 7.7d and e.  This 
measurement was calculated utilizing the time-lapse centroid locations of tracked cells at every 
time point.  Due to the influx of cells at later time points on day 1, more cells were available for 
tracking after the observed migration.  In comparison, day 7 did not show this movement.  Both 
instantaneous velocity plots showed a visual trend similar to a contractile motion, which is similar 
to previous studies [156]. 
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 To characterize the migration of cells toward the edge of wound, the output of 3D cell tracking 
was utilized.  The initial and final centroid locations of the tracked cell were used to calculate the 
total displacement, and then inverse tangent was utilized to calculate the orientation of cell 
migration in degrees of angle.  By quantifying cell migration in degrees of angle, it can be 
compared to other multimodal information, such as collagen orientation and NADH lifetime 
distribution. 
 
Figure 7.7.  Comparison between day 1 (a) and day 7 (b).  Noticeably increase in cell influx toward the wound edge 
in day 1 data was observed, as shown by fractional increase of cells overtime in (c).  In addition, Day 1 FLIM appeared 
to demonstrate longer NADH lifetime around the edge of wound.  These visual differences were not observed on 
day 7 (b).  Instantaneous velocity plots showed that day 1 (d) has more cells to be tracked at later time points.  Same 
visual difference was not shown on day 7 (e).  Scale bar: 200 m applies to all. 
 Analysis of cell migration on day 1 illustrated that most of the cells moved toward the direction 
of the edge of wound.  The relationship between cell migration and location of wound was clearly 
shown when representing the cell migration in a polar histogram, as shown in Figure 7.8.  
Additional interesting observation was made regarding the NADH lifetime distribution around the 
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edge of wound.  As can be seen in Figure 7.8, a visual difference in NADH lifetime can be seen 
around the edge of wound.  Area-based FLIM analysis was used to further quantify this observation 
by first randomly selected 5 small areas from region 1 and 5 areas from region 2 (Fig. 7.8).  Mean 
NADH lifetime of the region was calculated by averaging the mean NADH lifetimes of all 5 small 
areas in the region.  The area-based FLIM analysis showed a shorter lifetime in regions more 
distant to the wound compared to those surrounding the wound edge. Interestingly, cell migration 
was observed towards the wound edge corresponding to these areas of longer NADH fluorescence 
lifetime.  This observation can be visualized by comparing cell migration polar histogram with 
area-based FLIM analysis result, as shown in Figure 7.8.  In addition, Figure 7.9 below shows the 
NADH lifetime of each individual sub-area.  It is clear that overall, the regions near the wound 
edge have longer NADH lifetime than the regions further away from the wound. 
 
Figure 7.8.  Cell migration and area-based FLIM analysis of day 1 data set.  Cell migration polar histogram (left) 
showed most moving cells migrated toward the edge of wound.  Additional area-based FLIM analysis illustrated skin 
near the edge of wound (region 2) appeared to have a longer mean NADH lifetime than area further away (region 1). 
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Figure 7.9.  Area-based FLIM of all the sub-areas isolated to calculate the mean regional NADH lifetime shown in 
Figure 7.8.  The individual measurements show the area near the wound edge has longer NADH lifetime than area 
further away from the wound. 
This type of analysis was unique because tradition dual galvo-scanning and TCSPC FLIM 
detection would not have the imaging speed to easily perform cellular analysis on large FOV using 
in vivo data.  Comparing the results presented here to those from the study presented in Chapter 3, 
the data here showed information in the macroenvironment that can potentially allow user to 
connect in vivo cell motility to NADH lifetime distribution. 
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Figure 7.10.  Comparison of cell migration to cell orientation and collagen fiber angle distribution in the day 1 time-
lapse dataset.  In this data, initial cell orientation was more similar to cell migration direction, compared to collagen 
fiber angles.  Collagen fiber angles were calculated by the CT-FIRE function in the SHG collagen analysis module.  
A representative CT-FIRE analysis result is shown above.  The collagen structure displays a preference toward 
horizontal and vertical alignment relative to the image.  Scale bar: 50 m. 
 In addition to cell migration relative to NADH lifetime distribution, another parameter 
investigated was cell migration relative to cell orientation and collagen fiber angle.  To characterize 
the cell orientation, the orientation of the initial position of cells was calculated in degrees of angle 
utilizing the 3D tracking module.  By taking the advantage of spatially co-registered multimodal 
analysis, local collagen structures of all tracked cells were quantified using the SHG collagen 
analysis module.  Figure 7.10 shows that in day 1 data set, initial cell orientation was more aligned 
with the direction of cell migration compared to collagen fiber angles.  In addition, because the 
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dataset was acquired immediately after wounding, collagen structure did not show a specific 
direction of alignment, as shown in Figure 7.10.  The collagen fiber angle distribution shows there 
are no specific directions of alignment, but with a preference for horizontal (0° and 180°) and 
vertical (90°) alignment relative to the image (Fig. 7.10).  This observation is potentially related 
to the criss-cross pattern of uninjured collagen, and possibly due to the way collagen fibers align 
around the hair follicles.  Because the multimodal platform was capable of volumetric analysis, 
collagen fiber analysis can be performed on identical regions as the tracked cells identified in the 
3D cell tracking module.  In the dataset, it was not clear whether the cells preferentially moved 
along or across the collagen orientation since both patterns were observed. 
 To show that the analysis tool presented in this chapter is sensitive to collagen alignment, a 
comparison analysis was performed on a SHG collagen image from the study presented in 
Chapter 3.  Compared to the SHG image acquired in this chapter (Fig. 7.11a), the image from the 
IL-12 study (Fig. 7.11b) showed clear signs of collagen contraction.  The comparison analysis 
shows that when collagen contraction can be observed in the SHG image such as the one in Figure 
7.11b, the collagen analysis module can easily detect the visual differences (Fig. 7.11b).  In Figure 
7.11a, the SHG image did not show visible signs of collagen contraction, and therefore the fiber 
angle distribution showed a preference for both horizontal (0°/180°) and vertical (90°) alignment 
relative to the image itself.  In contrast, the SHG image in Figure 7.11b showed that majority of 
the collagen fibers aligned toward the center of wound, resulting in a fiber angle distribution 
centered around 90°, which is the preferred direction displayed in the image.  This comparison 
analysis confirmed that the collagen analysis module is sensitive to collagen orientation. 
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Figure 7.11.  Comparison analysis shows the sensitivity of the collagen analysis module toward collagen orientation.  
(a) A basket-weave collagen structure results in a fiber angle distribution with a preference for both horizontal and 
vertical directions relative to the image.  (b) A contracted collagen structure results in a distribution centered around 
the preferred direction. 
 Similar analysis was performed on day 7 dataset, where the same activity observed in day 1 
data was not present in day 7 data.  Cell migration and area-based FLIM were performed, and the 
cell migration results showed a more randomized migration direction compared to day 1 data 
(Fig. 7.12).  Area-based FLIM illustrated minor differences among the 4 different regions, which 
was unexpected because visual differences could not be detected.  However, the differences in 
lifetime across regions were more subtle than that in day 1 data.  Although cell migration direction 
was more randomized compared to day 1 data, a portion of the cells appeared to travel away from 
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the edge wound, as shown in Figure. 7.12.  A closer examination of the area-based FLIM analysis 
revealed that region 4 identified in the figure appeared to have slightly longer lifetime than the rest 
of regions, as shown in Figure 7.12. 
 
Figure 7.12.  Cell migration and area-based FLIM analysis on day 7 dataset.  Cell migration was more randomized 
compared to day 1 data, with a portion of cells moving away from the edge of wound.  The corresponding FLIM 
analysis showed small differences in mean NADH lifetime. 
Comparison among cell migration, cell orientation, and collagen fiber angles were also 
performed on day 7 data.  Similar observations were found, which showed that initial cell 
orientation was more aligned to the cell migration direction.  These results are illustrated in Figure 
7.13.  Similar to the previous data set, the collagen structure did not show visible signs of 
contraction.  As a result, the fiber angle distribution displays a preference for both horizontal 
(0°/180°) and vertical (90°) alignment relative to the image.  This result was reasonable because 
collagen contraction is often not observed until later time points during wound healing.  As 
discussed in Chapter 3, collagen contraction was not observed until 10 to 14 days after a wound 
was created.  Once again, the study shows that the multimodal analysis module developed in this 
chapter is sensitive to biological activities that were captured during in vivo imaging, and therefore 
is suitable for characterizing cellular dynamics in the microenvironment of skin. 
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Figure 7.13.  Comparison among cell migration, cell orientation, and collagen fiber angle distribution in day 7 time-
lapse data.  Cell migration direction was more similar to cell orientation, and the fiber angle distribution did not show 
clear signs of collagen contraction, as observed in the SHG collagen image.  Scale bar: 50 m. 
 The results presented in this section demonstrated numbers of biological parameters and 
phenomena that would be difficult to observe or characterized using traditional imaging and 
analysis techniques.  While many more cellular activities can be potentially characterized using 
the methods presented here, only a few were focused in this study to demonstrate both the 
importance of large FOV multimodal imaging and 3D characterization.  In addition, the study 
presented in this chapter is only the initial test on the applicability of both the video-rate 
microscope system and the multimodal analysis module.  Additional experiments should be 
conducted to evaluate this analysis module under different experimental conditions, and future in 
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vivo studies should be performed on an imaging volume that can serve better representation of 
three-dimensional region.  The imaging volume in future time-lapse cell tracking should cover a 
larger axial dimension without losing significant amount of lateral dimension and the time-lapse 
information. 
Furthermore, this multimodal imaging platform can be improved by adding different imaging 
modalities and analysis modules to include more biological parameters.  The addition of other 
imaging modalities and parameters can potentially expand the applicability of this analysis 
platform to other biological phenomena, including tumor microenvironment and neural activities.  
With the techniques presented in this chapter, the way in vivo cellular dynamics are evaluated can 
potentially be reinvented.  By observing and quantifying biological phenomena in ways similar to 
their native environment, researchers may gain additional insights into the pathological states of 
diseases. 
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CHAPTER 8: CONCLUSIONS AND FUTURE DIRECTION  
8.1 Summary 
The work presented in Chapters 3 through 5 covered numerous applications of the first-generation, 
conventional multimodal MPM OCM imaging platform in skin diseases, including evaluating the 
effects of recombinant interleukin on skin wounds, efficacy and mechanisms of stem cell treatment 
and topical ointment for non-healing diabetic wounds.  These applications both demonstrate 
multimodal MPM OCM as an effective tool for characterizing in vivo cellular dynamics in skin; 
however, they also revealed crucial limitations of the conventional system.  To better quantify the 
cellular dynamics in their native environment, Chapters 6 and 7 focused more on the engineering 
aspect of biomedical imaging by introducing the construction of the second-generation high-speed 
multimodal microscopy, and a multimodal analysis platform that allowed cross-modality 
quantification of various biological parameters.  In addition, a pilot study was executed to 
demonstrate the powerfulness of combining video-rate imaging and temporally and spatially co-
registered multimodal analysis tool.  Each result is a significant step forward for technological 
development in in vivo pathological screening and evaluation, and a starting point for new research. 
8.2 Continuing work 
8.2.1 Video-rate multimodal MPM OCM system 
Chapter 6 introduced the importance of a multimodal imaging system equipped with both MPM 
and OCT/OCM to thoroughly characterize the cellular and vascular systems in diseases.  In this 
study, a video-rate multimodal microscope was successfully constructed, and was proven powerful 
in acquiring large FOV TPF-SHG-FLIM co-registration imaging at a speed unparalleled by 
conventional dual galvo-scanning imaging system.  However, the addition of phase-sensitive 
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OCT/OCM was more challenging than originally anticipated.  The current state of OCM modality 
is capable of high-contrast structural imaging, but does not have sufficient phase stability to 
perform vasculature imaging.  The technical challenges and possible solutions for future 
improvement were detailed in Chapter 6.  In addition, future system development should consider 
improving the overall stability of the multimodal system, especially the phase stability of OCM 
for vasculature imaging.  Previous chapters had address the difficulty of acquiring PV-OCT 
vasculature images on the dorsal skin of mice, which prevented some wound healing studies 
presented in this thesis from being performed on this area of skin.  Instead, those studies were 
executed on the mouse ear skin.  While the ear skin offers reliable information for understanding 
the wound healing process, it is not an ideal representation of skin wound since it has limited 
collagen structure compared to dorsal skin and lacks adipose component.  Therefore, improving 
the overall stability of the imaging system and potentially optimizing imaging procedures may 
resolve the above challenge. 
 By designing an imaging system consisting of both multiphoton and vasculature imaging, 
relationship between cellular motility and metabolic activity in the skin microenvironment can be 
more directly observed and quantified.  Most importantly, it will strengthen the potential of this 
technology as an in vivo screening tool for novel treatments. 
8.2.2 Multimodal MPM-angiography analysis module 
As a follow up to the addition of vasculature imaging modality, the current multimodal analysis 
module can be further expanded to include longitudinal vasculature analysis.  As discussed in 
Chapter 5, many biological parameters can be quantified to describe the vasculature system.  An 
addition of this type of analytical module would allow researchers to investigate how metabolic 
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activity and cell motility relate to vasculature regeneration in living skin during wound healing, 
without excessive use of animals and/or exogenous fluorophores.   
 
Figure 8.1.  A decrease in vessel density around the wound edge (circled in yellow) from the same animal between 
days 10 (left) and 14 (right). 
 Figure 8.1 above is an example demonstrating the importance of including such analysis 
module.  The PV-OCT images from the angiogenesis-promoting topical cream study showed 
vessels disappearing from the edge of wound in one of the animals on day 14 (Fig. 8.1, right side).  
It was a particular interesting observation during the study; however, additional biological 
implications cannot be concluded because it was not possible to acquire large FOV TCSPC FLIM 
in a reasonable amount of time, to assess the change in metabolic activity around the edge of 
wound.  By using the current video-rate multimodal system, it would be possible to acquire the 
necessary information to observe possible differences in the regional metabolic state. 
8.2.3 In vivo 3D quantification of cellular dynamics in non-healing diabetic wounds 
With better optimized imaging system and analysis modules, it would be beneficial to re-examine 
the cellular dynamics in non-healing diabetic wounds.  Previous studies shed lights on the 
abnormalities at the molecular and cellular levels, which have helped researchers understand the 
underlying causes of non-healing diabetic wounds.  However, limited studies focused on 
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correlating the cellular activities to the molecular information.  Future studies can be focused on 
tracking differences in multimodal cellular activities among wounded diabetic skin, non-wounded 
diabetic skin, wounded normal skin, and non-wounded normal skin.  It would be particularly 
interesting to correlate immune cell activities to metabolic states during early wound healing, 
relationship among cell activities, collagen regeneration, and vasculature regeneration during the 
later stage of healing.  New information of the biological mechanisms of non-healing wounds may 
be uncovered, which would help future development of treatment for this type of skin disease. 
8.2.4 Identification of cell populations using in vivo data 
Although ex vivo cell cultures and histological staining are powerful tools to distinguish various 
cell types in the tissue, most of these techniques cannot be done on living tissue and not suitable 
for longitudinal study.  Proper identification of cell populations is crucial for diagnosing the state 
of diseases.  One example is differentiating M1 and M2 macrophages in both tumor and wound 
environment – while M1 is pro-inflammatory and help initiate the inflammatory reactions in 
microenvironment, M2 macrophage assists in tissue repairmen [23].  These two types of 
macrophages trigger completely different reactions in the biological system and significantly affect 
the state of disease.  Currently, it mostly requires antibody staining to differentiate the two types 
of macrophages, but through proper use of optical signatures and multimodal information, this 
type of cell classification can potentially be done using in vivo data.   
Besides macrophages, differentiating Langerhans cells, macrophages, and other immune cells 
in the tissue wound without using exogenous fluorophores and transgenic animal models would 
also be an incredible tool for the field of cellular dynamics.  Currently, limited studies have been 
done on realizing in vivo cell classification.  However, with the current state of multimodal 
multiphoton imaging technology, it will be possible to perform this type of analysis in the near 
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future, and significantly advance multimodal optical imaging in the field of disease screening and 
clinical applications. 
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